|
This section offers reader-friendly interpretations
of some of the more complex current events in hepatitis C,
including medical and scientific advancements. The following
articles have been compiled by Alan Franciscus, founder of
HCSP and HCVAdvocate.org.
Read current articles posted below,
or visit our News Review Archive
to read articles from previous years.
 This site includes links to files
you can view online or print. To download and print information,
you will need the latest version of Adobe Acrobat Reader.
Download
it free.
EASL 2013 Click Here
AASLD 2012 Click Here
EASL 2012 Click Here
AASLD 2011 Click Here
EASL 2011 Click Here
Top News 2013
 Free hepatitis testing for at-risk individuals—May 17, at the Health District, 3020 Rucker Ave, Suite 106, Everett.
May 12
Testing for HCV Infection: An Update of Guidance for Clinicians and Laboratorians
May 12
Hepatitis C RNA Testing Recommended for All Positive HCV Antibody Tests
May 12
HCC risk persists 8 years after HCV eradication
May 10
20 veterans test positive for hepatitis
May 8
CDC: 75 percent in U.S. with hepatitis C don't know they are infected
May 8
Many in U.S. don't get proper testing for hepatitis C: CDC
May 7
New Antiviral Treatment Could Significantly Reduce Global Burden of Hepatitis C
May 6
AbbVie's Investigational HCV Regimen Receives Breakthrough Therapy Designation from the U.S. Food and Drug Administration
May 6
Gairdner Foundation honours two of three prizewinners for hepatitis C research
May 2
Gilead combo hepatitis C pill effective in small trial
May 2
Updates from Amsterdam: HCV Emerging Therapies - Understanding the Science Behind the Clinical Data
May 2
Gastroenterology in the 21st Century: Optimizing Patient Outcomes
May 2
Targeted drugs to tackle hepatitis C
May 1
Hep C one of fastest-growing infectious diseases
May 1
Triple-drug HCV therapy comes with high risk of serious adverse events for people with cirrhosis
May 1
HCV screening of prison inmate drug users: an interview with Dr. Arthur Kim, Massachusetts General Hospital and Harvard Medical School
May 1
Sharecare Names Top 10 Social HealthMakers in Hepatitis C
May 1
Hep C quad regimens quashed, but some components go forward
April 29
Successful Hep-C Combo May Elude Patients as Gilead Goes Solo
April 29
Daclatasvir + sofosbuvir offers hepatitis C rescue therapy after current standard of care
April 29
BioLineRx Enrolls First Patient in Phase I/II Clinical Trial for BL-8020, an Oral, Interferon-Free Treatment for Hepatitis C
April 29
Attention Baby Boomers: Get Screened for Hepatitis C
April 27
Hepatitis C: Closing in on its viral origins
April 27
Anemia Top Side Effect of HCV Antivirals
April 27
Hemophilia Ontario wants paid plasma clinics delayed
April 26
Research finds targeted screening for hepatitis C is cost-effective
April 24
Hepatitis C found among Irish people who travelled overseas for dental treatment
April 24
Hepatitis c-like viruses identified in bats and rodents
April 24
Hepatitis C drug nears approval
April 23
Merck Enters Agreement with Bristol-Myers Squibb to Conduct a Phase II Clinical Trial Evaluating Combination of Investigational Oral Candidates MK-5172 and Daclatasvir for Chronic Hepatitis C
April 22
Dozens of Okla. dentist's patients positive for hepatitis
April 18
FDA Approves FibroScan for Non-invasive Liver Diagnosis
April 17
Benitec Selects University of California, San Diego as a Site for Phase I/II Clinical Trial of TT‐034 in Patients with Hepatitis C Infections
April 16
Achillion Initiates Phase 2 Interferon-Free Trial of Sovaprevir and ACH-3102 for Genotype 1 HCV
April 16
Roche to commercialize Hepatitis C drug in China with Ascletis
April 15
CROI 2013: Telaprevir Triple Therapy Improves HCV Response for Black Null Responders
April 12
Study reveals Rx target for HPV, Hep C and related cancers
April 11
Jury awards record $524M in Hep C case; lawyer calls verdict a wake-up call to health insurers
April 11
Daclatasvir/asunaprevir effective in difficult-to-treat HCV populations
April 11
Merck to Present New Data on VICTRELIS® (boceprevir) and Investigational Compounds MK-5172 and Vaniprevir for Chronic Hepatitis C Virus at The International Liver CongressTM / 2013 EASL Annual Meeting
April 10
ACTION ALERT: URGE YOUR MEMBERS OF CONGRESS TO SIGN ON IN SUPPORT OF VIRAL HEPATITIS FUNDING
April 10
HCV-infected patients bury heads in sand
April 10
Cardiovascular Issues Up Mortality Rates in Patients with Advanced Fibrosis
April 10
Bristol-Myers Squibb to Present New Data on Hepatitis C and Hepatitis B Compounds at The International Liver CongressTM (ILC) 2013
April 9
New mouse viruses could aid hepatitis research
April 9
Gilead Submits New Drug Application to U.S. FDA for Sofosbuvir for the Treatment of Hepatitis C
April 8
Hepatitis C spikes on Cape Cod
April 8
Device Keeps Human Liver Alive Outside Body
April 7
Canada: Report finds more people are dying from liver disease, calls for national strategy
April 6
Jury: HMO liable for $24M in Vegas hep C outbreak
April 5
Tears in court as victims of the 'largest hepatitis C outbreak in U.S. history' are awarded $24million
April 5
Daclatasvir/asunaprevir effective in difficult-to-treat HCV populations
April 5
Vertex Enters Agreement with Bristol-Myers Squibb for Phase 2 All-Oral Studies of VX-135 in Combination with Daclatasvir for the Treatment of Hepatitis C
April 5
Hepatitis C a hidden health threat: Oshawa man
April 4
Russell Morris - Russell Morris Backs Hepatitis C Campaign
April 4
Medicare patients need hepatitis C tests, coalition says
April 4
Incarceration, Marijuana Use and Suicide Attempts May Hinder Liver Transplant Eligibility
April 4
ACTION ALERT: Urge Your Members of Congress to Support Viral Hepatitis Funding In Their Appropriations Programmatic Requests
April 3
Formal HCV education improved time to therapy initiation, response
April 3
Liver diseases pose major problem in future for health care professionals: report
April 2
ChronTech's controlled clinical study of ChronVac-C® gives mixed results
April 2
HCV coinfection not predictive of kidney disease in liver transplant recipients with HIV
April 2
Congress must restore federal funding for needle exchange
April 1
Screen all psoriasis patients for hepatitis before immunosuppressive therapy
April 1
B.C. plan to wipe out hepatitis will follow HIV model
March 29
Oklahoma Dentist May Have Exposed Thousands To Disease
March 29
Janssen Submits New Drug Application to U.S. FDA for Simeprevir (TMC435) for Combination Treatment of Adult Patients with Genotype 1 Chronic Hepatitis C
March 28
Sofosbuvir combination shows promise in non-cirrhotic, treatment-naive HCV
March 28
A new drug shows promise of hepatitis C cure
March 28
'Sponge' Drug Shows Promise For Treating Hepatitis C
March 27
May is Hepatitis Awareness Month! Free & Low Cost Opportunities from CDC and local NGOs
March 27
Patients with HCV may deliberately skip early treatment doses when feeling well
March 27
Gilead Announces Update on Phase 3 Study of Oral Fixed-Dose Combination of Sofosbuvir and Ledipasvir for Genotype 1 Hepatitis C Patients
March 26
Hepatic Encephalopathy Explored in New Film, Clinical Studies
March 26
Hyperpigmentation common adverse event of interferon-based chronic HCV therapy
March 26
A new hepatitis threat—Hepatitis E
March 25
Temporary Tattoos May Put You at Risk
March 25
Millions on Verge of Diabetes Don't Know It: CDC –with comments by Alan Franciscus
March 22
Affordable Care Act extended free preventive care to 71 million Americans with private health insurance
March 22
Better Long-Term Outcomes With Low Hep C Viral Load
March 22
Duke Clinical Research Unit to Conduct Hepatitis C Clinical Trial
March 22
Gilead And Its Competitors In The Hepatitis C Race
March 22
Statins tied to lowered liver cancer risk with hepatitis C
March 21
Report highlights weaknesses in case of health worker who exposed thousands to hepatitis C
March 21
Hepatitis C Legislative Awareness Day In Albany
March 21
Data lacking on impact of psychosocial, behavioral factors on HCV treatment response
March 21
HCV Treatment in Special Populations
March 19
Sex between monogamous heterosexuals rarely source of hepatitis C infection
March 19
Newly incarcerated have 1 percent acute hepatitis C prevalence
March 19
Roche's Pegasys receives EU approval for the treatment of chronic hepatitis C in children five years of age and older
March 18
BioLineRx to Initiate HCV Study
March 16
Patients with HCV who failed prior therapy benefited from vaniprevir/peginterferon/ribavirin
March 16
Even moderate drinking may be risky with hepatitis C
March 15
Device keeps liver "alive" outside body in medical first
March 15
FAQ: The link between hepatitis C and liver cancer
March 15
CROI 2013: Updates on the Treatment of Hepatitis C (Video) with Liz HIghleyman
March 14
Study Shows Health Outcome in HCV Tied to Specialty Pharmacy Channel
March 14
Presidio Pharmaceuticals Announces Collaboration with Boehringer Ingelheim
March 13
Adding telaprevir improves acute hepatitis C treatment for HIV-positive men
March 12
N.Y. aims to prevent unsafe injections
March 12
Simeprevir pushes HCV cure rate above 75% for HIV/HCV co-infection
March 12
Eradication of Hepatitis C Virus Infection and the Development of Hepatocellular Carcinoma: A Meta-analysis of Observational Studies—with Comments by Alan Franciscus
March 11
Hep C Treatment Helps Stop Cirrhosis Progression in Those Coinfected With HIV
March 11
UC research uncovers hepatitis trend
March 10
Pfizer Stops Developing Hepatitis C Drug (filibuvir), Cites Strategic Review
March 8
Sofosbuvir combination efficacious in difficult-to-treat HCV patients
March 8
CROI 2013: Sofosbuvir + Ledipasvir + Ribavirin Combo for HCV Produces 100% Sustained Response
March 8
Vic doctor jailed for giving hep C to 55
March 7
The Petri Dish: Hepatitis C: another baby boomer legacy
March 7
Roche Gets FDA Approval For Hepatitis-C Therapy Response
March 6
The Perfect Cure for Hepatitis C?
March 6
All-Oral Regimens Work in HCV
March 6
Meal consumption confounds liver stiffness measurements in patients with chronic HCV
March 5
SBNC Offering Free HIV & Hepatitis C Testing--Santa Barbara, March 11, 2013
March 5
Patient Dilemma: Treat Hepatitis C Now or Hold Out?
March 4
Studies advance knowledge of HIV impact on hepatitis C infection and genes that may thwart HCV
March 4
Gilead-Medivir Hepatitis C Drug Clears Virus in Patients
March 4
First interim results from a phase IIa study evaluating an all-oral regimen of Simeprevir and Sofosbuvir in prior null responder Hepatitis C patients
March 4
Week-24 Interim Analysis of the TMC435-C212 Study in HIV and HCV Co-Infected Patients
March 4
Boehringer Ingelheim Announces Interim Results Evaluating Virologic Response Rates in HCV/HIV Co-Infected Patients Treated with Faldaprevir
March 4
Rural Hepatitis C patients receive care locally
March 4
Milk Thistle Drug May Help Control HCV Replication after Liver Transplant
March 3
FDA Hepatitis Update - Vicrelis (boceprevir) label changes
March 1
Addressing Hepatitis C Disparities in the African American Community
February 28
Help Lift the Ban on Funding of Needle Exchange
February 27
Hepatitis C testing offered at Health Fair this year
February 27
Chronic HCV linked to hypertension, congestive heart failure
February 27
Scientists are not divided over device that 'remotely detects hepatitis C'
February 27
SAMHSA Announces New Funding Announcement for Rapid Hepatitis C Screening in Drug Treatment Programs
February 26
The Hidden Costs of Health Care
February 25
Hepatitis C Outbreak Prompts Legislation
February 22
Postoperative peg-interferon plus ribavirin associated with reduced recurrence of hepatitis C virus-related hepatocellular carcinoma, with comments by Alan Franciscus
February 22
Regulatory Application has now been filed for Simeprevir (TMC435) in Japan for the treatment of genotype 1 hepatitis C patients
February 22
Clinical Effects of Viral Relapse after Interferon Plus Ribavirin in Patients coinfected with Human Immunodeficiency Virus and Hepatitis C Virus—with Comments by Alan Franciscus
February 21
Antioxidant Improves Donated Liver Survival Rate to More Than 90%
February 21
Durability of a sustained virological response, late clinical sequelae, and long-term changes in aspartate aminotransferase to the platelet ratio index after successful treatment with peginterferon/ribavirin for chronic hepatitis C: a prospective study—with Comments by Alan Franciscus
February 20
New Study on Hepatitis C Drug Treatment Yields More Accurate Estimate of HCV Half-Life
February 19
An Epidemiologic Update on Hepatitis C Infection in Persons Living With or at Risk of HIV Infection, with comments by Alan Franciscus
February 19
Australians gain access to new medicines to help cure hepatitis C
February 19
Gilead 's Sofosbuvir for Hepatitis C Meets Primary Endpoint in Fourth Pivotal Phase 3 Study
February 19
Fried foods have similar impact on your liver as hepatitis
February 16
Incident anemia improved response to peginterferon, ribavirin, boceprevir in HCV patients
February 16
Vitamin A deficiency reduced response to therapy for chronic HCV
February 15
FDA Hepatitis Update - Victrelis (boceprevir) label updates
February 15
13 found positive for hepatitis after hospital tests
February 14
Researchers Study Nurses' Knowledge of HCV Transmission
February 13
Carr talks Hepatitis-C cure
February 13
Studies Point to Advent of IFN-Free Regimens for Hepatitis C Infection
February 13
Souped-Up IFN Could Improve HCV Treatment
February 13
Anemia Management in Patients with Chronic Viral Hepatitis C (February) with Comments by Alan Franciscus
February 13
Use of HCV DAAs Differs From Clinical Trials
February 13
Sounding the Alarm on a Silent Epidemic: Federal HIV/STD Advisory Group Adopts Viral Hepatitis as Priority
February 12
Eligibility and safety of triple therapy for hepatitis C: lessons learned from the first experience in a real world setting—with comments by Alan Franciscus
February 12
Closing in on the Target: Sustained Virologic Response in Hepatitis C Virus Genotype-1 Infection Response-Guided Therapy
February 11
Mericitabine improved outcomes from peginterferon/ribavirin therapy for chronic HCV
February 8
French biotech rapidly stuck on losing side of hep C revolution
February 8
Campaign targets rising Hepatitis infections
February 7
Study Identifies Liver Gene that Regulates Cholesterol and Fat Blood Levels
February 7
Chronic Hepatitis Cohort Study Sheds Light on Burden of Hepatitis B and C in U.S.
February 7
Idenix Pharmaceuticals Discontinues Development of IDX184 and IDX19368
February 5
HCV Clinical Trials: Why One Might be Right for You
February 4
Two Phase 3 Studies Results of Sofosbuvir for Hepatitis C Released
February 4
Northern Kentucky sees spike in Hepatitis C rate
February 4
Viral Hepatitis Updates from CDC
February 1
Celsion Announces Results of Phase III HEAT Study of ThermoDox® in Primary Liver Cancer
January 31
Celsion plunges 80 percent as liver cancer therapy fails trial
January 31
Chronic hepatitis C: Interferon may be harmful in re-treatment
January 30
Genotype / Subtype Distribution in the United States
January 30
Medgenics kicks off trial of hepatitis C treatment
January 30
National Hepatitis C Survey Prompts Call for All Canadian Boomers to Get Tested
January 29
Referral and receipt of treatment for hepatocellular carcinoma in United States veterans: Effect of patient and non-patient factors
January 29
Treatment for Hepatitis C Virus Infection in Adults [Internet]
January 28
New Interferon-free Development Program
January 28
More bad news as BioCryst ditches hepatitis C candidate
January 28
FDA approves three new drug treatments for type 2 diabetes
January 28
An Interview with Alan Franciscus of the Hepatitis C Support Project (Part 2)
January 25
Treatment response improved neurocognitive function in patients with chronic HCV
January 25
Samsca (tolvaptan): Drug Warning - Potential Risk of Liver Injury
January 25
The Eye of the Needle
January 24
Second NY hospital warns patients about potential HIV, hepatitis exposure from insulin pens
January 24
IDSA urges USPSTF to reconsider HCV testing recommendation
January 24
Shorter surveillance periods detected smaller HCC in patients with viral hepatitis
January 24
An Interview with Alan Franciscus of the Hepatitis C Support Project (Part 1)
January 23
Tattooing poses HCV risk
January 22
New Ways to Study HCV, Genotypes 3 and 4
January 22
Rapid pace of liver damage in recent HCV co-infection
January 21
Lower Cognitive Scores in Women With HCV/HIV Than With HIV Alone
January 21
Inuit women’s group hosts hepatitis C gathering in Kuujjuaq next week
January 18
Edmonton hospital fed newborn hepatitis C-tainted breast milk, parents allege
January 18
Online tattoo and piercing kits could be spreading Hepatitis C
January 17
'Shame' discouraging hepatitis C treatment
January 17
New Research into survival of HCV outside of the syringe
January 17
Boehringer Ingelheim enrols first patients in pivotal Phase III interferon-free hepatitis C trial programme
January 17
Needle exchanges 'can curb Hep C'
January 16
Second patient tests positive for hepatitis
January 15
Economist Intelligence Unit Report Calls for Global Policy Innovation to Tackle the 'Silent Pandemic' that is Hepatitis C
January 15
Achillion Reports Interim Results on ACH-3102
January 14
Accidental Exposure: More Than 700 Patients May Have Been Exposed To HIV, Hepatitis At Buffalo VA Hospital
January 14
As Hepatitis C Sneaks Up On Baby Boomers, Treatment Options Grow
January 14
Charlotte Doctor Involved In Groundbreaking Hepatitis C Study
January 13
Water and Filters Used for Drug Injection May Transmit Hepatitis C Virus
January 13
Management of Chronic HCV in the Era of Protease Inhibitors
January 13
Decline in Available Liver Transplants Expected
January 10
Inovio Pharmaceuticals to Initiate Clinical Trial for its Hepatitis C Therapeutic Vaccine (INO-8000) Later this Year
January 9
Idenix says FDA seeks more time to review hepatitis C drug
January 9
After liver transplant for HCV, better antiviral results with cyclosporine
January 8
Study identifies promising new hepatitis C treatment
January 8
Gilead Provides Update on Hepatitis C Development Programs
January 8
Targeting Hepatitis C Treatment: The Importance of Interleukin (IL)-28
January 7
Gilead says on track with hepatitis C treatments
January 7
NIH investigators discover new gene that affects clearance of hepatitis C virus
January 7
Microbiotix Announces Exclusive Worldwide Licensing Agreement for HCV NS5B Non-Nucleoside Polymerase Inhibitors
January 7
Caxton Foundation announces the appointment as trustee of Ann Lloyd CBE
January 7
Competition affects who gets a liver transplant: study
January 6
Advocates slam delay in listing hepatitis C drugs
January 6
Interferon-Free Therapy For Hepatitis C May Become A Reality
January 4
New Pills Show Promise Against Hepatitis C
January 2
What The Health Law Will Bring In 2013
January 1
Top News 2012
Triple therapy with boceprevir improved SVR among HCV patients with fibrosis, cirrhosis
December 31
2012 Roundup—HCV Treatments
December 28
Doc whose Fremont clinic infected patients with hepatitis seeks N.Y. license to practice
December 27
Trying to halt hepatitis C's molecular hijacking
December 27
Patient Survival Rises When Drugs Suppress Hepatitis C in Blood: Study
December 26
Court tosses racketeering charge in hepatitis case, allows other charges against Las Vegas doctor to stand
December 25
Weighing the hepatitis C risk for baby boomers
December 24
4 More Hepatitis C Cases in Maryland Found Related To Infected Worker
December 22
Medivir announces initiation of the second cohort of the interferon-free phase II study combining Simeprevir and sofosbuvir for hepatitis C treatment
December 21
Chronic HCV linked to vitamin A deficiency, nonresponse to antiviral therapy
December 20
One Man's Harrowing Battle With Hepatitis C
December 20
Medivir announces phase III data for Simeprevir demonstrating efficacy and safety in genotype 1 hepatitis C patients
December 20
Incivek (telaprevir) In Combination with Drugs Peginterferon Alfa and Ribavirin (Incivek combination treatment): Drug Safety Communication - Serious Skin Reactions
December 19
Vertex Announces Update to U.S. Prescribing Information for INCIVEK® (telaprevir)
December 19
Fourth Street Clinic provides costly hepatitis C treatments
December 18
Hepatitis C: The Baby Boomer Virus: Lucinda K. Porter RN at TEDxGrassValley
December 18
Experts Propose New Terminology for Hepatitis C Drug Trials New Definitions Intended to Accelerate Innovation in Drug Development
December 17
HIV and Hepatitis C Coinfection Raises Cognitive Impairment Risk for Men
December 17
HIV+ MSM Have 4 Times HCV Risk of HIV-Negative MSM in Meta-Analysis
December 17
Professor Receives $1.6 Million to Study Potential Hepatitis C Drugs
December 14
HCV-Related Transplants Most Needed By Those Born 1941-60
December 14
Why the CDC's new hepatitis C recommendations for boomers are a no-brainer
December 12
Researchers find clue to how Hepatitis C virus harms liver
December 12
Triple therapy has poor safety in cirrhotic hepatitis C
December 11
Abstracts, presentations, posters, and photos from the 2012 National Summit on HIV and Viral Hepatitis Diagnosis, Prevention and Access to Care are now available
December 10
Most People with Hepatitis C Go Untreated, Despite Effective Drugs
December 10
Medicare funding threat lifted: After hep C outbreak, Exeter Hospital now meeting all conditions of participating in program
December 8
Gilead Sciences Leads The Race In Developing A Hepatitis C Pill
December 8
New Interferon Speeds HCV Virologic Responses
December 7
Delivery method, breastfeeding did not impact mother-to-infant HCV transmission risk
December 6
Aging Hepatitis C Population Escalates Demand for Liver Transplantation
December 6
The Medicare Open Enrollment period ends on Friday, December 7, 2012
December 4
Telaprevir and VX-222 pair well in interferon-free regimen, VX-135 on the horizon
December 3
Study results indicate potential link between chronic HCV, depression
December 2
Ex-hospital worker indicted in hepatitis C infections
November 30
Somagenics Holds Back on HCV Clinical Trial Amid Advances by Other Drugmakers
November 30
Lessons From The Liver Meeting: Sagient's John Tucker Names Companies That Could Reignite The Hepatitis C Industry
November 30
Liver Cancer Spikes Among Spanish Coinfected With HIV, Hepatitis
November 27
Sexual transmission of HCV among monogamous heterosexual couples: The HCV partners study
November 27
Zinc supplement helps hepatitis C
November 27
Less Support for Hepatitis C Testing for Baby Boomers
November 27
Gilead hepatitis C drug shows promise in late-stage trial
November 27
Sharing drug preparation equipment a potential source of hepatitis C transmission
November 27
Gilead Announces Sustained Virologic Response Rate of 78% from Phase 3 Study of Sofosbuvir for Genotype 2/3 Hepatitis C Infected Patients
November 27
Grapefruit Drug Interactions: Fruit Reacts Dangerously With Expanding List Of Medications, Study Says
November 26
Doctors should consider hepatitis C testing: panel
November 26
Devon Nicholson Hep C treatment Chronicles – Week 4 – "Blood Work and Virus Tests"
November 26
Mom, daughter won't let hepatitis C define them
November 25
Update: Local Veterinarian cured of Hepatitis C
November 22
National Summit on HIV and Viral Hepatitis Convenes November 26-28 in Washington With Focus on Accelerating HIV/Hepatitis C Testing and Reducing Disparities in Care
November 21
Triple Therapy Boosts HCV Response After Transplant
November 20
Simeprevir is safe and effective with interferon/ribavirin for hepatitis C patients with cirrhosis
November 19
Nail salons should be regulated to help prevent the spread of infections: report
November 19
Researcher hunts for hepatitis C cure
November 19
Ontario doctors question long wait for hepatitis C drug Incivek
November 19
FDA approves new indication for PROMACTA® (eltrombopag)
November 19
Many Physicians who Treat HCV Have Begun 'Warehousing' and Preparing HCV Patients for the Next Generation of Interferon-Free Treatments to Become Available, According to a Recent BioTrends Report
November 18
Heroin use linked to hepatitis C increase
November 18
KEY PHASE 2 HIV/HCV TRIAL COMMENCED
November 18
Hepatitis C Treatment's Side Effects Can Now Be Studied in the Lab
November 16
Hep C Protease Inhibitor Incivek Is Safe, Effective for HIV Coinfection
November 15
Interferon-free hepatitis C treatment safe, proves effective in up to 63% of patients with cirrhosis
November 15
Sofosbuvir demonstrates high response rate in interferon-free combination with ribavirin and GS-5885
November 15
Promising HCV Combo May Not See Light of Day
November 15
More coinfected patients receiving treatment for acute HCV
November 15
Peginterferon lambda-1a decreases viral load more quickly, safely than alfa-2a in HCV patients
November 15
INCIVEK™ (telaprevir) Now Funded in Alberta and New Brunswick for People with Hepatitis C
November 15
Veterans twice as likely to be infected with chronic hepatitis C
November 14
Abbott Announces Phase 3 Hepatitis C Program Details
November 13
Background liver proliferation linked to noncirrhotic HCC in patients with HCV
November 13
Weight-based ribavirin undertreats African–American HCV patients
November 13
Reducing ribavirin and adding EPO are both good anaemia management strategies for people taking boceprevir
November 13
Berkeley sued by estates of those who die in jail
November 12
Bristol-Myers, Achillion, Idenix show progress with oral hepatitis C drugs Read more: Bristol-Myers, Achillion, Idenix show progress with oral hepatitis C drugs
November 12
Novartis' Certican succeeds in liver transplant trial
November 12
New cohort shows the impact of hepatitis B and hepatitis C on the 'baby boom' generation
November 11
Gilead posts positive results in mid-stage Hepatitis C study
November 11
Abbott hepatitis C drugs bring high cure rates in trial
November 10
Gilead, Abbott Unwrap Dueling Hep C Pill Data
November 10
Boehringer Ingelheim Launches Hepatitis C Online Resource
November 9
Hepatitis C-infected doctor pleads guilty to 55 charges of negligently causing serious injury
November 9
Vertex's Incivek twice-daily dosing schedule insufficient to entice HCV patients waiting for new drugs
November 6
Europe Fails to Screen its Population for Hepatitis
November 6
Maryland confirms first hepatitis C case linked to arrested med tech
November 6
Radio show host calls organ donors heroes K100's Steele in 15th year of new life
November 5
Merck Will Initiate Interferon-Free Phase II Clinical Trials for MK-5172, an Investigational, Once-Daily, Oral Treatment for Chronic Hepatitis C Virus
November 4
Advanced liver disease and hepatic encephalopathy in the elderly
November 2
India revokes Roche hepatitis patent
November 2
FDA Hepatitis Update - Victrelis (boceprevir) labeling update—acute hypersensitivity reaction warning
November 2
Fortune teller: Mice with 'humanized' livers predict HCV drug candidate's behavior in humans
November 1
Vertex Tests Oral HCV Combos with Janssen and GSK
November 1
Living Donors Fare Well Following Liver Transplantation
November 1
Residents to get tested for HIV and hepatitis
October 31
BioCryst drops hep C drug on safety issues
October 31
Liver transplant survival higher among patients with NASH, HBV; lower for HCV, HCC
October 31
African American Women with HIV/HCV Less Likely to Die from Liver Disease
October 31
Hepatitis E vaccine debuts
October 30
HIV+ People Who Acquire Hepatitis C May Have Impaired HCV-specific Interferon Response
October 30
The case for speaking out on HCV
October 28
Few HCV/HBV infections identified in adults with access to care
October 27
Prisoners, hard hit by hepatitis C, decry lack of access to drugs
October 25
Patients with HCV, diabetes at greater risk for liver-related death
October 24
Long live your liver: Here's how
October 24
Primary care physicians miss hepatitis vaccine targets
October 23
State runs out of hepatitis blood test kits [Charleston Daily Mail, W.Va.]
October 23
Connecting Patients With Experimental Drugs
October 22
Antiviral therapy may halve risk of liver cancer after chronic hepatitis C infection
October 22
Don't Fear the Treatment
October 22
Hepatitis C Treatment Adherence Is Important for HIV/HCV Coinfected People
October 22
Low incidence of reinfection with HCV after treatment in active drug users
October 22
High Recurrence Risk for HCC Following Pegylated IFN Alpha-2b Plus Ribavirin
October 22
Unlicensed tattoo artists worrying health district
October 20
Liver cancer patient not wasting time
October 19
Vertex Draws Collaboration Interest For Hepatitis C Combo
October 19
Enanta's Lead Hepatitis C Compound ABT-450 Advances into a Phase 3 Clinical Trial through its Collaboration with Abbott
October 17
Biotron hepatitis treatment looks promising
October 16
BioLineRx Completes Pre-Clinical Development Of BL-8020
October 15
Rapid Tests Accurate in First-Line HCV Screening
October 15
Abbott's Hepatitis C Drugs Clear Virus in 99% of Patients
October 15
Abbott's Investigational Interferon-Free Hepatitis C Treatment Regimen Achieved SVR12 (Observed Data) Rates in 99 Percent of Treatment-Naïve and 93 Percent in Prior Null Responders for Genotype 1 Patients in Phase 2b Study
October 15
ICAAC 2012: Hepatitis C Can Be Successfully Treated in Injection Drugs Users with or without HIV
October 14
Patients with diabetes, chronic HCV at elevated risk for malignancies
October 14
Medical Reports: Hailey's Hope
October 12
Alternative-medicine doctor reprimanded, fined in hepatitis C outbreak
October 12
High testosterone may boost advanced liver disease risk
October 12
Prior alcohol consumption does not impair HCV treatment
October 12
Civil cases against NH hospital at center of hepatitis C outbreak put on hold
October 12
Veteran wins lawsuit over hepatitis infection he got at Fla. VA hospital; several US cases
October 12
Care center offers hepatitis C testing, support
October 11
Tawn Mastrey Foundation Presents/Headbangers Ball Reunion
October 11
Vitamin D deficiency associated with a poorer response to HCV treatment in HIV/HCV-co-infected patients
October 11
No cases found linking Ottawa endoscopy clinic to infections
October 10
Auditor General Jack Wagner Urges General Assembly, Health Dept. to Begin Licensing of Pa. Tattoo Parlors
October 9
New hepatitis C initiative launched in the Bay
October 9
Fighting Hepatitis C
October 9
N.J. health officials say needle exchanges work
October 8
Medicare: Inpatient or Outpatient?
October 5
HCSP Spanish Easy Facts (Datos Sencillos) Updated
October 4
Doctor stands by his actions at forum on hepatitis C study
October 4
IBTS retested more than 15,000 at risk of Anti-D/HCV
October 4
Hemispherx Biopharma Files for Treatment Expansion in Argentina for Alferon N Injection(R) for Hepatitis C
October 1
AMA pushes for safe injecting trial
October 1
The Next Big Thing in Biotech: Hepatitis Drugs
September 29
Don't rule out IFN/ribavirin for HIV patients with hep C cirrhosis: study
September 28
Janssen and Merck & Co share UK Prix Galien for hepatitis C drugs
September 28
VIEW : Intellectual bankruptcy — Syed Kamran Hashmi
September 27
Achillion heralds upbeat hepatitis C results as it rushes through Phase II Read more: Achillion heralds upbeat hepatitis C results as it rushes through Phase II
September 27
Treating Hepatitis C Infection in Prison is Good Public Policy
September 27
Interferon Free HCV Treatment: Simeprevir and ALS-2200 Enter Phase 2 All-oral Studies
September 26
Vertex Announces New Data on ALS-2200 in People With Hepatitis C, Supporting Advancement into Phase 2 All-Oral Studies in 2012; Ends Development of ALS-2158
September 25
Ethicists question doctor's pitch for a hepatitis C drug trial
September 25
Manitoba Adds Victrelis Triple to Pharmacare
September 25
Lawsuit seeks needle exchange programs for prisons
September 25
Kurk, Bradley criticize Hassan for cuts comment
September 22
Centre for Public Health report featured on BBC and ITV
September 21
World Hepatitis Alliance lands see no, hear no, speak no evil record to raise awareness
September 21
Idenix Pharma: Guilty By Association
September 21
Texas Tribune Weekend Insider: Hepatitis in Prison
September 20
A phase IIa interferon free combination hepatitis C trial of Simeprevir (TMC435) and TMC647055 will commence shortly
September 20
UK Research Aims to Reduce Spread of HIV and Hepatitis in Women
September 19
Achillion Back On The Hep C Roller Coaster Of Love
September 19
Trial of hepatitis C drug has deadly outcome for area man
September 18
Diets High in Fructose May Harm Liver in Some, Scientists Warn
September 18
Better Lasers Make Tattoo Removal Easier
September 18
1 more positive test in Hays for hepatitis C
September 16
Hepatitis C: A public health problem with a solution
September 15
Baltimore policeman shot in line of duty survives once again
September 14
Doctor says region needs clinic to help battle Hepatitis C
September 13
Limbrel (Flavocoxid) Linked to Acute Liver Injury
September 13
Lowering Ribavirin Dose During Telaprevir Therapy Does Not Compromise SVR in Patients With HCV
September 13
ICAAC 2012: HCV Polymerase Inhibitor Sofosbuvir Appears Safe and Effective for HIV/HCV Coinfected People
September 13
Increased Dietary Fructose Linked to Elevated Uric Acid Levels and Lower Liver Energy Stores
September 13
Ordeal of hepatitis C treatment worth it
September 12
Challenges remain in reaching 100% cure rate in HCV
September 12
Hepatitis C fight - 'watershed moment'
September 12
'Excellent' Survival Seen for Liver Transplant From Live Donor
September 12
Hepatitis C outbreak: Man gets 30 years for infecting patients
September 11
Warning over sirolimus in HCV-positive liver transplantation
September 11
Black Women With HIV and Hep C Less Likely to Die of Liver-Related Disease
September 10
Hepatitis epidemic must be tackled to stop liver cancer cases doubling
September 10
Time to lift hepatitis C stigma
September 10
Holyoke's arrival at needle exchange a rough road despite doctors, other specialists trumpeting its effectiveness
September 9
Impact of ribavirin on response in HIV patients with acute/early HCV
September 9
Increase of Hepatitis seen in the Four States
September 6
Survival "Excellent" Following Living Donor Liver Transplantation for Acute Liver Failure
September 6
Love your liver
September 5
Chronic hepatitis C virus infection increases risk of death from both liver disease and non-liver-related causes
September 5
Prison nurse tied to hepatitis C exposure at Buckeye facility
September 5
Arizona inmates possibly exposed to Hepatitis C
September 4
N.H. hospital resists turning over patient records in Hep C case
September 4
Upcoming FREE NeedyMeds Webinars in September
September 4
HSE's national strategy for hepatitis C to be published
September 3
Hepatitis C outbreak prompts call for drug testing of health care workers
September 2
Triple Infection with HBV Promotes HCV Clearance in People with HIV
September 2
Early treatment could clear Hepatitis C
September 1
Pledge Today To Educate Yourself and Others About Hepatitis C
September 1
Antibody prevents hepatitis C in animal model
August 30
SLU Liver Center is at forefront of new hepatitis C treatments
August 30
Theatre to raise awareness of Hepatitis C
August 29
Achillion Deal Looming as Hepatitis Drugs Fail: Real M&A
August 29
Why Boomers Should Get Tested FactSheet from the CDC
August 28
Vt. baby boomers urged to test for hepatitis C
August 27
Idenix Pharma (IDIX) Says Clinical Hold Placed on IDX19368 by FDA
August 27
Hepatitis C-The "Diabetes-Curious" and Self Inkers/Piercers at Risk
August 26
Former gallery owner fights hepatitis C in Sacramento amid calls for widespread testing
August 26
NH hospital workers urged to get tested following hepatitis C outbreak blamed on lab worker
August 25
Bristol-Myers Squibb Discontinues Development of BMS-986094, an Investigational NS5B Nucleotide for the Treatment of Hepatitis C
August 23
All Nelson area boomers encouraged to test for hepatitis C
August 23
Kansas: Third Hays patient tests positive for Hep C
August 23
"Pharma Greed Kills!": AIDS Activists Take On Hepatitis C
August 23
Australia: PBS decision on Hepatitis C drugs looms
August 23
Response to HCV Therapy Lowers Non-Liver HIV Progression, Death
August 23
Tattoo Inks Pose Health Risks
August 23
More than 60 test positive for hepatitis, but state finds no link to Dean Clinic incident
August 22
CDC Urges Molecular Testing as Follow Up for Positive HCV Antibody Test Result
August 22
The Register editorial: Hepatitis C shows value of health law
August 21
FDA: Reumofan Products Pose Risk to Consumers
August 21
Hepatitis C test for baby boomers saves lives
August 21
Maui AIDS Foundation Helps with New Hep C Recommendations
August 21
Testing the limits
August 20
Infections Among Homeless Could Fuel Wider Epidemics, Study Suggests
August 20
Pakistani son gives new life to mother on his birthday
August 19
Who's to blame in hepatitis case?
August 19
What Hepatitis C Tells Us About Drug Use And Addiction
August 18
Recording Hepatitis C: A Patient's Treatment Journal
August 17
Molecular and protein markers discovered for liver transplant failure from hepatitis C
August 16
Is The Hep C Drug Pipeline Beginning To Crack?
August 16
Idenix hepatitis C drug (IDX184) put on partial hold
August 16
The National Viral Hepatitis Roundtable Welcomes CDC's New Hepatitis C Screening Guidelines
August 16
CDC says: "Born 1945 - 1965? Get Tested for HCV
August 16
Exeter Hospital Hepatitis C Victim Toll Rises
August 15
HCV Type and IL28B Gene Affect Risk of Death in HCV/HIV-Positive
August 15
Laurier students face slight risk of Hep B,C, HIV after class test
August 15
Kansas Updates Potential Hepatitis C Exposures at Hays Medical Center Information
August 14
Major Breakthrough in Hepatitis C Vaccine Development
August 14
Piercing plan for jailbirds incites fury
August 13
New Approach to Treat Acute Liver Failure
August 13
Test all baby boomers to detect hepatitis C, a slow, silent killer (Canada)
August 10
Idenix To Forge Ahead On HCV Combo After Novartis' Departure
August 10
Height, Weight and BMI Changes Seen in Children Treated with Peginterferon Alpha for Hepatitis C
August 9
Hepatitis A Vaccination in Children under Two Remains Effective for Ten Years
August 9
A New Mexico experiment aims to fix the doctor shortage – no new doctors required
August 9
Hepatitis C panel looks at drug-testing
August 9
Achillion Announces Positive SVR4 Results From Phase 2 Study of Sovaprevir (Formerly ACH-1625) and Advancement of ACH-3102
August 7
Exeter Hepatitis C Victim Toll Rises: 31
August 7
Living in the shadow of hep C
August 7
St. John Hospital and Medical Center in Detroit Issues Testing Warning
August 7
Three health care staffing firms face reviews after hepatitis outbreak
August 6
Temple offers hep C testing
August 6
Locations of hepatitis C testing clinics announced
August 6
Stricter body-piercing law takes aim at teenagers
August 6
Thousands to be tested for hepatitis C in New Hampshire
August 3
Free HIV, HCV Testing, Maui
August 3
Triple Therapy Workbooks for Patients Taking Boceprevir or Telaprevir
August 3
Bristol-Myers Squibb Suspends Administration of Study Drug in Clinical Trial of Investigational NS5B Nucleotide for the Treatment of Hepatitis C - BMS-986094 (formerly known as INX-189)
August 2
Las Vegas Hepatitis C Outbreak Claims First Victim
August 1
10th Patient Treated in Extract-1 Study - Analyst Blog
August 1
Saint Luke's to offer free hepatitis C screenings
August 1
Researchers pinpoint peptide that blocks hepatitis C virus entry
August 1
Liver transplant patients who taper off or do not take corticosteroids after transplantation have better quality of life
August 1
FDA Hepatitis Update - Victrelis (boceprevir) label updated for drug-drug interactions
August 1
Obese Donors Increase Risk of Death for Pediatric Liver Transplant Recipients
August 1
Drug users fuel rise in number of Blackburn and Darwen Hepatitis C cases
July 31
The good, the bad and chronic hepatitis
July 31
Vertex Announces Positive Results from Viral Kinetic Study of the Nucleotide Analogue ALS-2200 in People with Hepatitis C
July 30
4 Michigan Facilities Linked to Hepatitis C Investigation
July 30
In Memoriam: John Plater
July 30
Presidential Proclamation -- World Hepatitis Day, 2012
July 30
Foreign media disclose hepatitis numbers on World Hepatitis Day 2012
July 30
Canceled Hepatitis C Tests Flame 'Serial Infector' Fears
July 29
10 to 12 million Pakistanis infected with hepatitis B and C
July 29
Event highlights hepatitis dangers
July 29
Washington Call for Access to HCV Diagnostics, Treatment and Care for All!
July 29
Finland: 1,000 cases of hepatitis-C diagnosed annually
July 28
World Hepatitis Day, 28 July 2012
July 28
OraSure Technologies Supports Rapid HCV Testing Initiatives for World Hepatitis Day
July 27
Pennsylvania hospitals to conduct hepatitis C testing
July 26
Hepatitis C suspect tied to Phoenix hospitals
July 26
Decompensated liver disease more frequent in HIV/HCV co-infected people
July 26
Boomers beware: Hepatitis a silent pandemic in Mendocino County
July 25
Rising numbers of hepatitis C patients treated for liver disease
July 25
Ligand Partner GlaxoSmithKline Announces Priority Review for Supplemental New Drug Application for Promacta(R) for the Treatment of Thrombocytopenia in Adult Patients with Chronic Hepatitis C Infection
July 25
IDX719 Receives Fast Track Designation From the FDA for the Treatment of Chronic Hepatitis C Infection
July 25
World Hepatitis Alliance Welcomes New Global Framework Aimed at Saving the Lives of Millions Living With Hepatitis
July 24
Official: 6,000 more people to be tested for hepatitis C
July 24
CDC: Hepatitis C suspect Kwiatkowski worked in eight states
July 24
NIH Scientists Identify Likely Predictors of Hepatitis C Severity
July 23
Michigan Among Seven States Wrapped Up in Hepatitis C Probe
July 23
Many Canadians can now be cured of hepatitis C but more trained nurses and doctors are needed
July 23
Vibrio Warning: Europe
July 22
Shirked duty alleged in hep C nightmare
July 22
Kansas hospital warns patients about hepatitis C
July 21
6 other states check for hepatitis
July 21
Canadian HCV management guidelines released
July 21
Hospital worker charged in NH hepatitis C outbreak
July 19
Hepatitis C may increase deaths from both liver-related and other diseases
July 18
Milk Thistle, Taken by Many People for Liver Disease, Ineffective as Treatment for Hepatitis C, Study Suggests
July 17
Vitamin B12 May Significantly Enhance Standard Hepatitis C Treatment
July 17
Insulin Resistance Linked to Liver Disease Progression in HIV/HCV Coinfected Patients
July 17
N.H. hospital to offer new treatment for hepatitis C victims
July 17
Woes of a fatty liver
July 16
FDA Approves First Medication to Reduce HIV Risk
July 16
8,000 patients advised to get HIV, Hepatitis tests after dentist caught reusing needles & syringes
July 15
A stealthy killer, hepatitis C needs wider screening
July 15
Hepatitis C Rates Rise Among Johnson County Young Adults
July 13
Loyola Establishes New Division of Hepatology
July 13
Colo. officials: Dentist reused syringes, needles
July 13
Majority of people with HCV infection may be unaware of condition
July 13
Deschutes County needle exchange program running out of money, needles
July 12
Tapestry Health Begins Needle Exchange Program in Holyoke
July 12
"Ask Me about Hepatitis C" Palm Card – Now Available
July 12
Current and Former Smokers at Risk for Recurrent Hepatitis Post-Liver Transplantation
July 12
Springfield-Greene County Health Dept. Begins Hepatitis C Testing
July 11
Alcoholic hepatitis linked to hepatitis C risk
July 10
HCV Genotypes Are Differently Prone to the Development of Resistance to Linear and Macrocyclic Protease Inhibitors
July 10
Volunteer for NIAID Hepatitis C Clinical Research Studies
July 10
Liver Stiffness Predicts Liver Failure, Cancer and Mortality in Cirrhotic Patients Coinfected with HIV/AIDS and HCV
July 10
Levels of Hepatitis C Virus Higher Among African Americans and Males
July 10
Bulgaria Launches Development of National Hepatitis Plan
July 9
Biolex to liquidate after burning $190M on hep C drug
July 9
Hepatitis C treatment offers new hope
July 9
Local clinics offer rapid results for hepatitis C
July 9
Debate over Abbotsford's needle exchange ban
July 7
Antibody Gets High Marks in Small Hepatocellular Carcinoma Trial
July 7
Hepatitis C outbreak at Exeter Hospital in N.H. grows to 27 cases, lawsuits follow
July 5
MedMira Wins $4.2 million U.S. Army Contract to Commercialize Rapid Triple Test
July 4
3D-printed sugar network to help grow artificial liver
July 3
Let's get the facts straight on hepatitis C
July 3
Idenix: New HCV Drug Could Be A Blockbuster
July 3
NH hepatitis C outbreak grows to 27
July 2
ESTIP urges Egyptian patients and liver experts to avoid new unproven Hepatitis C treatments
July 1
New law could affect victims of hepatitis C
June 29
EASL-AASLD Special Conference on Therapy of Hepatitis C: Clinical application and drug development
June 29
Medivir announces an interferon-free phase II combination trial with TMC435 and daclatasvir to commence shortly
June 29
Hepatitis C patients petition for life-saving drug combination
June 28
Supreme Court upholds healthcare law in Obama triumph
June 28
Hepatitis C doctor talks about positive outcomes
June 27
Exeter hepatitis C infections rise to 21
June 27
Hepatitis C doctor talks about positive outcomes
June 27
New National Hepatitis C Referral Resource Maps
June 26
Presidio Pharmaceuticals Successfully Completes Phase 1 Proof-of-Concept for PPI-668, its Potent HCV NS5A Inhibitor, in Hepatitis C Patients with Genotype-1 Infection
June 26
Clipboard: The case for speaking out on HCV
June 25
RiverStone Health offers free HIV and Hepatitis C testing Wednesday, July 27
June 25
Hepatitis: UCSF and San Francisco at Ground Zero
June 23
Senate Passes Bill To Make NJ Needle Exchange Program Permanent
June 22
Hepatitis C support group sharing insights and battling stigmas
June 22
New Legislation Proposed After Hep C Outbreak
June 21
Man exposed to hepatitis C at hospital 'dumbfounded'
June 21
Idenix Announces Positive Clinical Data for HCV Drug Candidates IDX184 and IDX719
June 20
Study May Offer Support for DPP HCV Test
June 20
FBI Joins Criminal Probe of Hep C Outbreak
June 19
Boomers' hep C tests may torpedo insurance chances, experts say
June 19
HCV suppression reduces liver damage
June 19
HIV/hepatitis C co-infection increases risk of hip fracture
June 19
Arthritis therapy tied to liver injury cases
June 18
Scripps Research Scientists Show Lack of Single Protein Results in Persistent Viral Infection
June 17
Hepatitis C outbreaks elsewhere similar to NH's
June 17
More than 2 dozen blood samples botched in hep C probe
June 16
New hope for rising tide of boomers with hepatitis C
June 15
CytoPharm and Amarillo Biosciences Announce Positive HCV Study Results: Oral Interferon Found to Reverse Thrombocytopenia; Reduced Relapse Rate Seen in Patients with Mild Fibrosis
June 15
Drug diversion suspected in NH hepatitis C cases
June 13
Doctors in Europe and the US disagree over the pace of liver fibrosis in men co-infected with HIV and hepatitis C
June 13
1-800-GET-THIN clinics put patients at risk, lawsuit alleges
June 13
Former state Sen. Burt Cohen encourages Baby Boomers get tested for hep C
June 12
Rapid testing a breakthrough in fight against hepatitis C
June 12
More than 27 percent of L.A. homeless adults have hepatitis C, and nearly half don't know it
June 11
THE DUEL: Abbotsford misses mark in passing controversial bylaw
June 11
One-use blood-test device was used with about 80 teens
June 10
Exeter Hospital Hepatitis C Victim Total Rises – Again
June 9
Bill To Expand Needle Exchange Pilot Program Advances
June 7
Successful Pregnancies Possible for Women Following Liver Transplantation
June 7
Exeter Hospital Hepatitis C Outbreak Gets Worse
June 6
Comedian Mike MacDonald Puts Spotlight On Bigger Killer Than HIV
June 6
St. Michael's Opens Center Dedicated to Treatment of Liver Disease
June 5
Kadmon Launches 600 mg/day Ribasphere® RibaPak® to Provide Added Dosing Control for Triple Therapy Treatment of Chronic Hepatitis C
June 5
Exeter Hospital employee among known hepatitis C patients
June 5
Transplant Fundraiser for Andrea Johnson
June 5
Safe in Common to Exhibit at APIC Annual Educational Conference
June 4
N.H. among few with no mandate to report hepatitis C
June 3
Quality of Life Undiminished by Telaprevir in Chronic Hepatitis C
June 2
Inmates remain at risk for HIV and HCV after release from prison
June 2
More hep C cases but no needle decision
May 31
Exeter Hospital: 4 diagnosed with hepatitis C
May 31
FDA says Vertex promotional material overstates benefits of hepatitis C drug
May 31
Curative Hep C Treatment Benefits Non-Liver Health and Survival in HIV
May 31
Boise Bands to Stand and Deliver Against Hep C Wednesday, June 6, at Neurolux
May 30
Top 5 Diseases That Are Misdiagnosed In African Americans
May 30
Addressing Viral Hepatitis at the Department of Veterans Affairs
May 30
GSK seeks to expand low platelet drug Promacta to hepatitis C patients
May 30
Clean needles provided to reduce disease in drug users
May 29
Get in fight early to beat sneaky hepatitis C virus
May 28
Webinar Announcement: CDC Overview of HCV Screening Guidelines
May 24
HealthWatch: Seale, Alabama man says his hepatitis C is gone; credits research group
May 23
U.S. Liver Transplants Declining
May 23
Hep C coming back to haunt baby boomers: An interview with Lucinda K. Porter, RN
May 22
Experts Discuss DAAs for Difficult-To-Treat Hep C Patients
May 22
Achillion Announces Additional Proof-of-Concept Data With ACH-2684 for the Treatment of Hepatitis C
May 21
Bay Area health advocates and doctors welcome recommendations
May 21
Addict doctor 'spread hep C'
May 21
CDC Announces First Ever National Hepatitis Testing Day and Proposes that All Baby Boomers Be Tested Once for Hepatitis C
May 18
Orange County: Free Hepatitis Testing and Vaccines Friday and Saturday
May 18
Hepatitis C increased in rural Wisconsin
May 18
CDC Releases Birth Cohort HCV Screening Guidelines and Funding Announcement
May 18
Telemedicine Program Improving HCV Care for Rural Veterans
May 18
Patient group rouses Oakland against the 'Silent Killer'
May 18
OraSure Technologies Announces Rapid HCV Testing Initiatives for First National Hepatitis Testing Day
May 18
Mayor Lee and U.S. Centers for Disease Control (CDC) Kick Off Historic 1st National Hepatitis Testing Day in San Francisco
May 18
All baby boomers should get hepatitis C test -CDC
May 18
Mansfield Ohio Health Department Offering Hepatitis C Screening
May 17
Hawai'i: State offering free Hepatitis B & C testing
May 17
The struggle against Hepatitis C
May 17
Hep-C increasingly affecting county's young people
May 17
Incivek Rash Reports: What HIV/Hepatitis C-Coinfected People Need to Know
May 17
Class action over hepatitis C scandal
May 16
Ribavirin Helps Early Hepatitis C Treatment in People with HIV
May 16
Medical Edge: Liver Treatment—Magnetic Resonance Elastography, or MRE
May 15
Ottawa comedian's kidneys, liver shut down
May 15
Gastroenterology Special Issue Focuses on New Directions of Viral Hepatitis Care and Research
May 15
ACH-3102 Receives Fast Track Designation From the FDA for the Treatment of Chronic Hepatitis C
May 15
Syringe exchange programs reduce disease and save taxpayer dollars
May 14
One Racing Family's Journey to Create Hepatitis C Awareness & End it Once & For All. Comedian Susan Dale Recently Shared Her Families Story at Business Event in Tulsa, OK
May 14
OKC Woman Stuck by Syringe Inside Peat Moss
May 13
Thomas Jefferson University Hospital Creates Comprehensive Hepatitis C Center
May 11
Mayo Clinic technician pleads guilty to spreading hepatitis C
May 11
Charges stand in hep C case against former doctor
May 11
Guest Commentary: Baby boomers and hepatitis C in Colorado
May 11
B.C. foster mom has Hepatitis C lawsuit dismissed
May 10
Newsmaker: Paul Plaisir, hepatology nurse, discusses Hep C
May 10
Achillion Advances Second Generation Pan-Genotypic NS5A Inhibitor, ACH-3102, Into Clinical Development
May 9
U.S. may speed approval of 'breakthrough' drugs
May 9
Aethlon Medical Reports Undetectable Hepatitis C Virus (HCV) in Genotype 1, Genotype 3, and Genotype 5 Patients Treated with Hemopurifier® Therapy
May 8
EASL 2012 Promising Findings for Therapeutic Hepatitis C Vaccine TG4040
May 8
Declaring war on Hepatitis-C: Free screenings Libby Montana
May 8
Hepatitis C warning as home tattoo kit sales rise
May 8
Intensive Follow-up Reduces Mortality from Hepatocellular Cancer
May 7
Fraser Health urges Abbotsford to get rid of anti harm-reduction bylaw
May 7
Bristol-Myers Missing Hep C Data Raises Red Flags, May Boost Gilead, Idenix
May 7
Liver transplants in HIV-HCV co-infection—results from a U.S. study
May 7
Co-infection with hepatitis C increases mortality risk by 50% for patients with AIDS
May 6
As a Tribute to His Father, Secada Wages War on Hepatitis C
May 5
Pitt dental school accused of negligence, using dirty equipment
May 5
B.C.'s medical officer raises question over blood-sample bill
May 5
Free Hepatitis Testing Day Statewide Hawai'i – Friday, May 18, 2012
May 5
Board reprimands nurse who potentially exposed patients to hepatitis, HIV
May 5
SPECIAL REPORT: Teens & Tats ... Paying the price
May 4
Medical marijuana backers have six weeks to collect signatures for ballot question
May 4
Being an organ donor
May 4
Second Annual Zebrowski Walk On May 12
May 4
Opening a New Chapter in HCV: Focus on Successful Outcomes with HCV Protease Inhibitor Therapy A Virtual Education Summit
May 3
Opening a New Chapter in HCV: Focus on Successful Outcomes with HCV Protease Inhibitor Therapy A Virtual Education Summit
May 3
Boy undergoes HIV, hepatitis treatment after finding syringe at Oakland playground
May 3
Hepatitis C infections grow at an alarming rate
May 3
Hepatitis C Cases on the Rise in Northern Kentucky
May 2
Prison puzzle: Treating hepatitis C
May 2
Interferon linked with increased risk of depression in HCV patients
May 2
Hepatitis C a latent legacy of baby boomers' youth
May 2
Facebook to Promote Organ Donation; May Benefit People With Hep C or HIV
May 1
Hepatitis Awareness Month at the CDC
May 1
Maybe There Will Be Some Hep C Patients Left
April 28
Ryan White: Back, But Not Without Issues
April 28
U.S.: Do not mix Merck hepatitis pill with HIV drugs
April 26
Patient Survival Not Impacted by Liver Transplants Performed at Night or on Weekends
April 26
NICE has given its final recommendation for two new hepatitis C pills in an expedited review
April 25
Updated Event and Training Workshop Schedules
April 25
Abbotsford drug use trending up, Hep C rates high: Fraser Health report shows
April 24
INCIVEK(TM) (telaprevir) Now Funded for People With Hepatitis C in Quebec and Saskatchewan
April 24
Aethlon Medical Note: An Unprecedented Data Point, The Single-Treatment Capture of Hepatitis C Virus (HCV) by the Aethlon Hemopurifier®
April 24
Family History of Liver Cancer Increases Risk of Developing the Disease
April 24
Fibrosis and Fatty Liver Disease Increase Risk of Early Atherosclerosis
April 24
Achillion Pharma slumps on hepatitis C drug data
April 23
Mobile hepatitis C screening to be held in four Warwickshire towns
April 23
Sharing the gift of life: Local couple in need of organ transplant raises organ donor awareness
April 21
FDA Hepatitis Update - Victrelis (boceprevir) label change reflects drug-drug interaction information with HIV protease inhibitors
April 20
National Hepatitis Testing Day (May 19) Site Now Live
April 20
Patient dies during Novartis clinical trial of Alisporivir
April 19
Medivir Announces TMC435 in an Expanded Clinical Collaboration
April 18
National Hispanic Hepatitis Awareness Day 2012 Official Website Launch
April 18
Government tries to have foster parent's Hepatitis C lawsuit tossed out of court
April 17
The Race To Create The Best Antiviral Drugs
April 17
ELPA Coverage of EASL 2012
April 17
Needle exchange program opens doors to city's most vulnerable population
April 16
Inked or infected: Tattooing comes with risks
April 14
Silent epidemic calls out for cure
April 14
Liver Fibrosis Tests Predict Mortality in HIV/HCV Coinfected Women
April 14
Man grateful to be alive after doctors at the U. performed a transplant first
April 12
San Diego City Council Grants $51,000 for Needle Exchange Program
April 12
Taking Your Hepatitis C Triple Therapy
April 12
In Memoriam: Michael Carden 1971-2012
April 12
Cirrhosis and hepatitis C to be discussed at forum
April 11
Issues go unsolved at St. Louis VA medical center
April 11
Drug injection sites urged for Ottawa, Toronto
April 11
Discordance between CD4 cell count and percentage associated with markers of liver disease in HIV/hepatitis C co-infected people
April 10
Man Who Contracted Hepatitis C Sues Dean Health
April 10
Report : Cochran VA hasn't solved dental issues
April 10
$1.1 M for hepatitis C screenings and treatment
April 9
Bristol-Gilead Hep C Drug Data Leaks
April 9
What You Don't Know, You Can Sell
April 9
Staff catch hepatitis C from dirty needles while working at NHS Greater Glasgow & Clyde
April 8
Hepatitis C poses a silent crisis
April 6
Lessons Shared from Transmission of Hepatitis C Infection to Patients
April 6
Hepatitis C infections now twice as likely in HIV+ gay men as in injecting drug users, Swiss study finds
April 6
In hepatitis C: Curing the incurable
April 5
Jon Secada's new single is a love song to his Dad
April 5
Mass. residents, representatives discuss Hepatitis C prevention
April 4
Promising Vaccine Targets On Hepatitis C Virus
April 4
Abbott to Present Positive Phase 2 Results from Multiple Interferon-Free Studies of Combination Regimens for the Treatment of Hepatitis C
April 4
Metformin Helps Some Cancer Patients
April 3
Nurse lobbying for hep C treatment changes
April 2
Tremelimumab Shows Promise in Treatment of Liver Cancer
April 2
Save the Date - HCV Tribal Summit: May 9th and 10th, 2012 Shooting Star Hotel and Casino Mahnomen, MN
April 2
Over 20 Million Individuals Infected with Hepatitis E in Asia and Africa
April 2
Detection and Treatment for Hepatic Encephalopathy Prevents Car Accidents, Reduces Costs
April 2
Increasing Routine Viral Hepatitis Testing
March 30
Hepatitis C Review: Acetaminophen - Tylenol
March 29
Hepatitis C Information and Support Group with Book Signing
March 30
Arizona Supreme Court hears Mesa tattoo case
March 29
HIV, Hepatitis C rapid testing now in D.C.
March 29
Video - Featuring Hepatitis C Advocate Shari Foster
March 28
Antiretroviral rollout provides a model for efforts to expand hepatitis C treatment and care in resource-limited settings
March 28
VICTRELIS™ Now Available for Eligible Patients in British Columbia
March 28
CROI 2012: Two hepatitis C drugs greatly increase HCV cure rates in co-infected people
March 28
Screening for hepatitis C in jail
March 28
Scots hepatitis campaign praised in European study
March 26
Chlamydia, Hepatitis C lead diseases reported by Ross health district
March 26
New manual provides guidance in addressing viral hepatitis in people with substance use disorders
March 26
Cops challenge Tattoo cover up rule
March 26
Tattoo competition to include local artist
March 26
Liver Cancer Patients Less Likely to Die on Wait List than Candidates without Carcinomas
March 22
Liver disease deaths jump 25% in England: study
March 22
 Action Alert - Act Now: End Federal Funding Ban on Syringe Exchange Programs
March 21
Top court rules against two diagnostic patents
March 19
Discovery Provides Blueprint for New Drugs That Can Inhibit Hepatitis C Virus
March 19
877-HELP-4-HEP; a Peer Advocacy Success Story
March 19
Needle exchange program is a health care necessity
March 19
CROI: HIV/HCV Coinfection News from CROI 2012 [VIDEO]
March 18
New York City hitting hepatitis C
March 17
Treating HIV During Pregnancy Also Lowers Risk of Transmitting Hep C to Baby
March 17
NICE recommends Incivo for hepatitis C
March 16
BCRX challenges Biota patent, claims its hepatitis C compound was first
March 16
Liver Transplant Program at Methodist Specialty and Transplant Hospital Recognized as Best in the Nation
March 15
Broader screening for hepatitis C would be cost effective, study suggests
March 15
Updated Hepatitis C Evaluation and Treatment Guidelines from Bureau of Prisons
March 14
Okairos announces initiation of Phase I/II clinical trial for potential first-in-class hepatitis C vaccine
March 14
Hepatitis C Infection Increasing Among Adolescents, Young Adults
March 13
Medivir announces new studies in phase III program for TMC435
March 13
Familiarity With Drugs Helps a Group Speak for Users
March 12
New Hep C meds may override watchful waiting for patients with no symptoms
March 11
Wilmington tattoo shop shuttered by Delaware health division
March 10
Court revives suit over NY prison medical care
March 9
Merck's hepatitis C drug wins UK cost endorsement
March 9
Hepatitis C test helps curb Egypt epidemic
March 9
ACTION ALERT: Urge Your Members of Congress to Ensure Our Nation Is Properly Funding Viral Hepatitis Programs
March 8
National Consumer Protection Week and FDA's Fight Against Health Fraud Scam
March 8
Results from Investigational Studies with VICTRELIS™
March 7
HCV vaccine – it’s coming in big steps
March 7
National Day of Action for Syringe Exchange
March 7
*ACTION ALERT* Call your member of Congress today about the CDC Hepatitis C Screening Guidelines!
March 7
Scientists Develop Better Test for Identifying Hepatitis Type
March 6
Data from Phase 2 Study of an INCIVEK® Combination Regimen Showed 74% of People Co-Infected with Hepatitis C and HIV Had Undetectable Hepatitis C Virus 12 Weeks After Treatment Ended (SVR12)
March 6
Prison dispatch: Hepatitis epidemic could become costly
March 6
Patients with hepatitis C virus infection who adhere to their drug regimen are more likely to show long-term benefit
March 6
Tattoo you? Beware the Dangers
March 5
Jerry Davich: Dear boomers, are you positive that you're negative?
March 4
Experts stress Hepatitis C testing, awareness
March 4
Cirrhotic Patients Experience Increased Daytime Sleepiness from Higher Ammonia Levels
March 2
Hypoferremia Predicts Treatment Response to IFN-α
March 2
New Treatment Improvement Protocol (TIP), Addressing Viral Hepatitis in People With Substance Use Disorders
March 1
*ACTION ALERT* Urge Your Members of Congress to Support Viral Hepatitis Funding In Their Appropriations Programmatic Requests
March 1
Cholesterol-Reducing Statins, Other Meds to Be Avoided With Hep C Protease Inhibitors
March 1
Lieutenant Kurt Beach recovering from Hepatitis C after trying to save baby
March 1
Hepatitis C subtype-1b and carriage of IL28B gene associated with improved treatment responses in HIV-co-infected patients
March 1
Vertex Announces 12-Week On-Treatment Data and SVR4 From Phase 2 Study of Interferon-Free (All-Oral) Treatment Regimen of INCIVEK®, VX-222 and Ribavirin in People with Genotype 1 Hepatitis C
February 29
Ultrasound Technology Proves Accurate in Diagnosing Cirrhosis from Recurrent Hepatitis C
February 29
How FDA Ensures the Safety of Blood Products
February 29
Vancouver Island Hep C victim caught in Catch-22
February 29
World Hepatitis Alliance - Newsletter
February 28
Stanford scientists model hepatitis C treatment options
February 28
Point-of-Care HCV iPhone/iPad App from Projects In Knowledge
February 24
Doc: All Should Be Screened For Hepatitis B, C
February 23
HepQuant to Begin Clinical Study of Liver Function Measurement Tests
February 22
Enanta's Hep C drug deal with Novartis worth up to $440M
February 21
Hepatitis C protease inhibitor therapy cost effective in some circumstances
February 21
Hepatitis C deaths up, Boomers most at risk
February 20
Gilead Suffers First Hep C Drug Setback
February 17
Gilead Announces Data for Genotype 1 Null Responder Hepatitis C Patients Enrolled in ELECTRON Study
February 17
Virology Profile Following Treatment With ACH-1625 Discussed in Oral Presentation at 2012 Asian Pacific Liver Conference
February 17
Lack of donor organs and poor access to treatment mean mortality rates for liver disease destined to rise
February 16
Singer Jon Secada Joins Merck and American Liver Foundation's 'Tune In to Hep C' Public Awareness Campaign (Spanish Version–En Español)
February 16
Hepatitis C Community Advisory Board (HCAB) DDI statement
February 16
Alberta researchers develop vaccine to fight hep C
February 15
Hepatitis C on increase in Dunedin
February 15
BioCryst Announces Promising Results from Preclinical Studies of BCX5191 for Hepatitis C
February 15
Bristol-Myers Squibb Completes Acquisition of Inhibitex, Inc.
February 14
New stand on heroin at Footscray addiction clinic
February 13
President's Budget Restores Community Control on Federal Funding for Syringe Exchange
February 13
Professional tattooing in sterile environment not associated with risk of hepatitis C
February 13
Complete early virological response was highly achieved by double filtration plasmapheresis plus IFN-beta induction therapy for HCV-1b patients with relapse or no response after previous IFN therapy
February 13
Saugus family hopes for conclusion in benefits battle
February 12
Illegal tattooing on the rise in Surry County
February 12
Making History: Eliminating Viral Hepatitis Disparities in the African American Community
February 10
Interferon and ribavirin control HCV genotype 6
February 9
VICTRELIS™ (boceprevir) and Ritonavir-Boosted HIV Protease Inhibitors May Indicate Clinically Significant Drug Interactions for Patients Coinfected with Chronic Hepatitis C and HIV
February 8
Amateur tattoos carry hepatitis C risk: CDC
February 7
As death nears, hepatitis C victim to give videotaped deposition in Desai case
February 7
NIH Launches "Clinical Research Trials and You" Website
February 6
BioLineRx In-Licenses Second Oral Hepatitis C Treatment
February 6
Alanine Aminotransferase Levels ID Liver Disease Risk
February 4
Idenix Announces Removal of the Partial Clinical Hold on HCV Nucleotide Inhibitor, IDX184
February 3
Inability to work due to work-related injury alone curbs nurse's claim
February 2
Even in sickness, EMT from West Haven strives to help others
February 2
Coffee Consumption Reduces Fibrosis Risk in those with Fatty Liver Disease
February 2
Aethlon Medical Reports Immediate and Rapid Virologic Responses in Hepatitis C (HCV) Patients Receiving Hemopurifier® Treatment Protocol
February 1
Hepatitis A vaccination rates vary greatly from state to state
January 31
Cardiopulmonary Exercise Testing May Predict Post-Liver Transplantation Survival
January 31
Cell Permeable Peptide Identified that Inhibits Hepititis C Replication
January 30
Stem cells may shed light on hepatitis, MIT researchers find
January 30
Alcohol Treatment Boosts Hep C Cure Rates Among Drinkers
January 30
Sign the Syringe Exchange Program Ban Position Statement
January 30
Scientists show brain vulnerable to Hepatitis C virus
January 18
Israelis find vitamin D helps against liver diseases
January 17
Kidney failure risk higher for liver transplant patients following allocation policy change
January 16
Researchers Discover Means for Blocking Hepatitis C Infection
January 16
FREE HIV and Hepatitis C testing coming to Guerneville Jan 18, 2012
January 15
CDC Warns Against Sharing Insulin Pens
January 14
Hep C threat to health services
January 13
Merck Hepatitis C Drug May ‘Anchor' Future Worldwide Regimen
January 10
Alarming Incidence of Hepatitis C Virus Re-Infection After Treatment of Sexually Acquired Acute Hepatitis C Virus Infection in HIV-Infected MSM
January 10
New Target and FDA-Approved Cholesterol-Lowering Drug Identified for HCV Therapy
January 10
No link yet between hepatitis B, C cases and Ottawa clinic
January 10
New Fibrosis Classification Improves Accuracy of Diagnosis in Hepatitis C
January 10
High Rates of Disability and Health Care Use for Older American with Cirrhosis
January 10
Achillion Reports Clinical Data on Portfolio of Protease Inhibitors
January 9
Presidio Pharmaceuticals Reports Progress with Hepatitis C Antiviral Programs
January 9
Idenix Reports Advancement of HCV Development Pipeline
January 9
Idenix Reports Positive Interim Data for HCV Nucleotide Inhibitor, IDX184
January 9
Bristol-Myers Squibb to Acquire Inhibitex
January 8
Researchers Identify Liver Cancer Risk Factors
January 7
HCV Antivirals Cost-Effective for Injecting Drug Users
January 7
ACH-1625 Receives Fast Track Designation From the FDA for the Treatment of Chronic Hepatitis C
January 4
Therapies Can Extend Life in Infiltrative Liver Cancer
January 4
Experimental hepatitis C vaccine shows early promise
January 4
Experts Issue Early Guide for Hep C Protease Inhibitor Therapy in People Living with HIV
January 3
Can-Fite BioPharma Announces Successful Results of its Phase I/II Liver Cancer Study with its CF102 Drug; the Study Achieved the Primary and Secondary Endpoints
January 3
Hepatitis C virus hijacks liver microRNAs to survive
January 3
Mayo study links hepatitis C to liver cancer
January 3
As part of new program, two St. Luke's patients receive liver transplants
January 1
Top News 2011
Free pipes distributed to curb disease
December 31
Participants Needed for Hepatitis C Treatment Study. Reimbursement Available
December 29
Gregg Allman touts importance of hepatitis C testing, reflects on his recovery
December 29
Peregrine Provides Update on HCV Clinical Program
December 29
Incivek and Victrelis Usage as Part of Triple Therapy Hepatitis C Regimen is Emerging as the New Standard of Care for Genotype 1 Patients According to a Newly Released Report by BioTrends Research Group
December 23
Incivo approved in Scotland
December 23
Hepatitis outbreak grows
December 23
Child gets hepatitis C from transplant at Boston hospital
December 22
Drug Users in California to Have Better Access To Clean Needles
December 21
Safe injection site plan is scientifically sound: health official
December 18
Congress to Restore Federal Syringe Exchange Funding Ban as Part of 2012 Spending Package
December 17
Safety (Still) Trumps Acquisitions in Hep C
December 17
Research could solve donor liver shortage
December 16
Outbreak of Hepatitis A on Vancouver Island Hitting Aboriginals Hard
December 16
Pharmasset Halts Studies with PSI-938
December 16
Merck and Roche team up for hepatitis C studies
December 16
Clinical Care Options Launches CCO Hepatology inPractice™, Adding a Third Specialty to its Comprehensive Online Resource
December 16
Pharmasset Announces Intent to Amend QUANTUM Trial
December 16
URGENT ACTION REQUESTED: Syringe Exchange Federal Ban
December 15
Obesity and Diabetes Epidemics Spur Increase in Nonalcoholic Steatohepatitis
December 15
Doctors say they have no duty to lock up sedatives
December 12
Amick: The needle exchange debate
December 12
Federal funding for syringe exchange is under attack!
December 12
Hepatitis C cases drop in P.E.I. since opening of needle exchange
December 12
Patient Advocate Foundation Announces $9.3 Million Donation to their Co-Pay Relief (CPR) Program
December 10
Hepatitis C Medicines Save Lives in Cambodia
December 9
Vertex and Alios BioPharma Begin Clinical Studies of Nucleotide Drug Candidates ALS-2200 and ALS-2158 for the Treatment of Hepatitis C
December 9
Boehringer Ingelheim completes patient entry for Phase III trial programme in Hepatitis C
December 9
HCV Infection May Predict Coronary Artery Disease
December 8
Lipid-modifying enzyme: New target for pan-viral therapeutics
December 7
Biotron brings hope for Hepatitis C sufferers
December 7
Limitations in Liver Cancer Screening Uncovered
December 6
New Jersey Legislators OK needle exchange program
December 6
Achillion Announces Preliminary Phase 1b Proof-of-Concept Data With ACH-2928 NS5A Inhibitor for the Treatment of Hepatitis C
December 5
Too promiscuous to donate an organ? Maybe, CDC says
December 5
In The Spotlight-HCV Advocate and Ms. Lucinda K. Porter, RN.
December 5
Ottawa's crack pipe exchange is working, study finds
December 2
Medivir - TMC435 will be evaluated in a phase II combination study with daclatasvir (BMS 790052) for HCV genotype-1 patients
December 2
Low-Dose IL-2 Induced HCV Vasculitis Remission
December 1
Living in fear of dying
December 1
Transplant Candidates Seek "Best Quality" Livers Despite Having to Remain on Waiting List
December 1
Green Tea Flavonoid May Prevent Reinfection with Hepatitis C Virus Following Liver Transplantation
December 1
Studies of Patients with Cirrhosis Uncover Limitations in Liver Cancer Screening
December 1
FDA Hepatitis Update - CLIA waiver expands availability of rapid blood test for antibodies to the hepatitis C Virus (HCV)
November 29
Hepatitis common at Washington Penitentiary
November 29
Drug-resistant Hepatitis C
November 29
Bread of Healing Clinic connects patients with needed drugs, care
November 27
The redlining of harm reduction programs
November 24
'May I Be Frank': A Life-Changing Documentary
November 23
Hepatitis Screening Offered With Routine Colonoscopy Accepted by 75%
November 23
VICTRELIS™ Now Available for Eligible Patients in Ontario
November 22
University launches iphone app for hepatitis treatment
November 22
Gilead to Buy Pharmasset for $11 Billion to Win in Hepatitis
November 21
4 Hep C cases found after Ottawa clinic scare
November 16
UPMC organ transplant program placed on probation
November 15
Liver Cancer: Increasing Incidence, But Greater Therapeutic Options
November 12
CDC Poised to Advise Screening Baby Boomers for HCV
November 10
Adherence to Hepatitis C Treatment Interventions: A Comparative Effectiveness Review
November 10
Incivek, Victrelis Working Well in HIV/HCV Coinfection Studies
November 10
New FDA Website: Needles and Other Sharps (Safe Disposal Outside of Health Care Settings)
November 9
The Crisis of Hepatitis C and Intravenous Drug Use
November 9
Patients With Chronic Viral Hepatitis Should Be Tested for Vitamin D
November 9
A Note on Hepatitis C Treatment and Medigap
November 9
Liver donors have complaints years later: study
November 5
New 12 Week, Interferon-Free Treatment Arms Added to All-Oral Combination Study of PSI-7977 and Daclatasvir (BMS-790052) for HCV Genotype 1
November 4
New 12 Week, Interferon-Free Treatment Arms Added to All-Oral Combination Study of PSI-7977 and Daclatasvir (BMS-790052) for HCV Genotype 1
November 4
Inhibitex skyrockets on promising oral Hep C drug program
November 4
Impact of sirolimus on HCV progression in liver transplant recipients
November 4
Persistence of very low levels of virus increase risk of relapse after hepatitis C therapy
November 4
Hepatitis C transmission via injecting drug use: look beyond needles and syringes
November 4
Birth cohort screening for hepatitis C is cost effective, could save thousands of lives each year
November 4
Vertex Announces Recipients of Special Grants Initiative to Support People with Hepatitis C
November 4
Putting an end to viral hepatitis: America's silent killer
November 3
U.S. Assistant Secretary for Health Speaks On Important Bay Area Efforts to Eradicate Viral Hepatitis
November 3
Medivir Announces Final Results from TMC435 Phase IIb ASPIRE (C206) Study
November 2
Pharmasset Announces the Initiation of an Interferon-Free Phase 3 Program with PSI-7977 for HCV
November 1
Notes from the Field: Risk Factors for Hepatitis C Virus Infections Among Young Adults --- Massachusetts, 2010
October 29
Vertex Starts Global Phase 3b Study to Evaluate the Potential for People with Hepatitis C to Achieve a Viral Cure (SVR) with a Total Treatment Duration of 12 Weeks of INCIVEK™ Combination Therapy
October 24
Boehringer Ingelheim announces new data from hepatitis C virus portfolio
October 22
European studies on risks of hepatocellular carcinoma
October 21
Abbott says hepatitis C combo may be a blockbuster
October 21
Interim Phase IIb Data for Merck's VICTRELIS(TM) (boceprevir) in Patients Coinfected with Chronic Hepatitis C and HIV-1
October 20
New European HIV treatment guidelines expand treatment recommendations
October 18
SF leaders unite to call on mayoral candidates to end liver cancer and hepatitis
October 18
People on methadone can succeed on hepatitis C treatment
October 18
Inovio Pharmaceuticals and VGX International to Advance Therapeutic Hepatitis C and Hepatitis B Synthetic Vaccines into Clinical Studies
October 17
Roche's All-Oral Hep C Therapy Could Be First, Not Best, to Reach Market
October 17
Roche Buys HCV Therapeutics Firm Anadys for $230M in Cash
October 17
Largest Ever Genetic Study of Liver Function Could Point the Way to New Treatments
October 16
6,800 may be exposed to HIV, hepatitis infection at Ottawa clinic
October 16
Gene variant that helps hepatitis C treatment may hinder HIV treatment
October 15
Yale research reveals novel aspects of virus-fighting protein
October 14
From Needle Stick to Cure for Hepatitis
October 14
UC San Diego School of Medicine Launches Hepatitis C Clinical Trials
October 13
Anadys Announces Positive 12-Week Data for Setrobuvir in Phase 2b Hepatitis C Study
October 13
Project ECHO brings faraway specialists close to home
October 12
Americans Discard 7.8 Billion Needles Every Year
October 12
AFP Level Predicts Mortality in Hepatitis C-Related Liver Cancer
October 12
Transgene Announces Important Update on its HCVac Study with its Therapeutic Vaccine TG4040 in Chronic Hepatitis C
October 12
Gov. Jerry Brown signs bills expanding drug user access to syringes
October 11
Scripps Research receives NIH grant to determine how HCV induces liver cancer
October 11
Engineering Hope: Curing Hepatitis C
October 11
Inovio, VGX to develop vaccines for Hepatitis B and Hepatitis C
October 11
INCIVEK™ (telaprevir) Now Available in Canada for People with Hepatitis C
October 11
INCIVO® (telaprevir), a new treatment for genotype-1 chronic hepatitis C launched today
October 10
BIT225 Hepatitis C Phase 2A Trial Positive Results
October 10
Pharmasset Announces Further Expansion of ELECTRON Trial in Hepatitis C
October 10
Deferasirox Can Improve Liver Fibrosis, Necroinflammation
October 1
'Micro'-Chemo and Cancer Pill Combo Tested in Liver Cancer Patients
October 1
Mallory-Denk Bodies on Biopsy Predict Fibrosis Progression in HCV
October 1
Hepatitis C in the U.S. May Be Underestimated by Over a Million
September 30
Safe drug-injection site can stay: Supreme Court of Canada
September 30
Hepatitis C patients likely to falter in adherence to treatment regimen over time, Penn study shows
September 30
Alcohol impairs the body's ability to fight off viral infection
September 30
Consider Hepatitis C Infection in Some Arthritis Patients
September 29
Updated Hepatitis C Practice Guidelines Now Available from AASLD C
September 28
High-Risk Donor Livers Used with Greater Frequency in Transplantations C
September 28
Liver Cancer Incidence Lower in Nonalcoholic Fatty Liver Disease Patients than in those with Hepatitis C
September 27
Living Donor Liver Transplantation Improves Survival Over Deceased Donor Transplants
September 27
Peregrine Completes Patient Enrollment in Randomized Phase II HCV Trial for Bavituximab
September 26
'Step Up To The Plate' Against Hepatitis C
September 24
European Medicines Agency Recommends Restricting Use of Dronedarone
September 22
CDC: New proposed guidelines for organ transplantation
September 22
Pittsburgh Couple Sue Hospital Over Hepatitis C-Infected Kidney Transplant
September 21
SomaGenics' sshRNA Technology Demonstrates Efficacy of RNAi Against Hepatitis C Virus
September 21
Vertex, J&J hepatitis C drug (Incivo) gets EU nod
September 20
Danger Signal Limits Hepatitis C Infection
September 19
How our liver kills 'killer cells'
September 19
Shark-Derived Drug May Treat Viruses
September 19
Rapid anti-HCV tests can provide sensitive and specific anti-HCV results for high-risk patients
September 19
Inhibitex Commences Dosing of Phase 2 Clinical Trial of INX-189 in HCV Infected Genotype 2/3 Patients
September 19
Sanford Guide Introduces New Hepatitis Guide
September 18
Coffee Helps Minimize Hepatitis C Treatment Side Effects
September 16
Early Data on BMS-790052 HCV NS5A Inhibitor Published
September 16
Hepatitis B and C Coinfection among HIV Positive People in the U.S.
September 16
High viral cure rate achieved with a 24-week INCIVEK combination regimen
September 14
Genotyping HCV Patients for HLA-C and IL28B Improves Ability to Predict Treatment Response
September 14
Needle exchange program in the works for county's IV-drug users
September 13
Pharmasset Initiates QUANTUM, a Phase 2b Interferon-Free Trial of PSI-7977 and PSI-938 for All HCV Genotypes
September 13
Drug users help boost hope for hepatitis C vaccine
September 12
New Treatment Options Are On The Horizon For People Co-Infected With HIV And Hepatitis C Virus
September 7
Pharmasset Announces 91% SVR12 From the PROTON Trial in Subjects With Hepatitis C Genotype 1
September 7
Gilead Amends Study Design for Ongoing Hepatitis C Clinical Trials That Include GS 9190, Pegylated Interferon and Ribavirin, and Another Direct-Acting Antiviral Agent
September 5
New Hep C drug priced out of reach of most patients
September 1
Clinic may have exposed patients to HIV, hepatitis: How to stay safe
September 1
Poor healthcare in Victoria's jails a "major threat"
September 1
Changes to Distribution of Livers for Transplant Proposed
August 31
Bruce DeVenne Dies of Cancer
August 31
Ignored Virus Can Cause Liver Cancer, Study Suggests; Should We Be Screening Blood for Hepatitis G?
August 24
FDA Approves Pegasys/Copegus for Pediatric HCV Infection
August 24
Pharmasset receives fast track designation for Hep C drug PSI-938
August 24
HIV Linked to False Negative Hep C Results Using Some Rapid Assays
August 23
Dual Hepatitis B, C Infection Ups Lifetime HCC Risk
August 23
Patient Advocate Foundation Announces Additional Support for Patient Co-Pay Relief Program Serving Breast Cancer, Colon Cancer, Hepatitis C Patients
August 22
Vertex Pharma Says Health Canada Okays INCIVEK For People With Hepatitis C
August 22
Blacks With HCV May Benefit Most From Boceprevir and Telaprevir
August 22
Radioembolization Improves Chance of Survival for Liver Cancer Patients
August 22
Saffron Shows Promise in Preventing Liver Cancer
August 22
Step up to the plate against Hepatitis C
August 21
Use of New HCV Protease Inhibitors 'Not That Simple
August 16
Scotland faces Hep C timebomb with 30 new cases every week
August 10
In Memoriam: Emmet B. Keeffe, MD
August 8
New Book on Hepatitis C: James with a Silent C
August 8
Investigators Identify Inactivating Mutations in Tumor Suppressor Gene ARID2 in HCV-associated HCC Patients
August 5
Victrelis (boceprevir) Approved in Canada
August 3
Chronic Hepatitis C Genotype 1 Drug, Victrelis (Boceprevir) Launched In UK Today
August 3
Counseling, Drug Treatment Can Increase Hep C Treatment Eligibility
August 3
Vancouver Coastal Health tries new approach to reduce spread of hepatitis C
August 2
Going to the Cubs game? Get tested too
August 2
Chronic hepatitis C estimated at 9.2 million individuals in Middle East and North Africa
July 31
United Kingdom: Programs May Curb Hepatitis C in Drug Users
July 30
New vaccine for hepatitis C virus
July 29
National Minority Quality Forum Launches the Hepatitis C Index
July 28
Safe injection sites needed Canada-wide to fight hep B, C
July 28
Hepatitis B and C Prevalent in Injecting Drug Users
July 28
Boceprevir response and resistance differs according to HCV genotype 1 subtype
July 28
Interim Data from Phase 2 Study of Combination Regimen Including VX-222 and INCIVEK™ Suggest Potential to Treat Genotype 1 Hepatitis C in as few as 12 Weeks and No More Than 24 Weeks
July 26
Hepatitis C is transmitted by unprotected sex between HIV-infected men
July 21
Pharmasset Announces Final SVR Data from PROTON trial with PSI-7977 in Subjects Infected with Hepatitis C Infection Genotype 2 or 3
July 20
Walgreens Specialty Pharmacy Drives Adherence for Hepatitis C Patients Through Therapy Management Program
July 19
Transplant Error Finds More at Fault
July 19
Crack Pipes 'Not Authorized' in Kits
July 19
Health Officials Work to Curb Mercer Co. Hepatitis
July 18
VICTRELIS(TM) (boceprevir), First-in-Class Oral Hepatitis C Virus Protease Inhibitor, Approved in the European Union for Treatment of Chronic Hepatitis C
July 18
Tainted-Blood Victims Not Told about Compensation Availability
July 17
Vaccination Rates Up for Those With Liver Disease, Diabetes
July 15
UPMC Gets Approval to Restart Living Donor Transplant Programs
July 15
Local Drug Programs Aim to Contain Spread of Infections
July 14
Achillion Announces Initiation of Phase 1 Trial of ACH-2928 for the Treatment of Hepatitis C
July 12
Health 411: Medicare Guidance Is Here
July 11
NIOSH Launches New STOP STICKS Campaign Website
July 11
Medicaid Improves Health and Budgets of Poor
July 7
Pharmasset Enters into a Clinical Collaboration Agreement with Tibotec Pharmaceuticals for a Combination Study in Patients Chronically Infected with Hepatitis C
July 6
TMC435 Has Received Fast Track Designation from the FDA and TMC435 Will Be Studied in Combination withPharmasset's PSI-7977 for HCV Genotype-1
July 6
Hepatitis C Cases in Region on the Rise
July 5
Living Donor Liver Transplantation from a Donor Previously Treated with Interferon for Hepatitis C Virus: A Case Report
July 3
Safe Crack Kits Face Challenges in Use: Study
July 3
Genetic Variant Linked to Development of Liver Cancer in Hepatitis C Virus Carriers
July 3
Innovative Vaccines with Nanotechnology
July 1
Programs May Curb Hepatitis C in Drug Users
June 28
Affordable Care Act Delivers Cheaper Prescription Drugs to Nearly 500,000 People
June 28
Gene Variant Increases Fatty Liver Risk and Fibrosis Progression
June 28
Hepatitis C on the Rise in Mercer County
June 27
Liver Fibrosis Tied to Hep C-Related Vasculitis Prognosis
June 24
FDA Urges Caution on Amgen, J&J Anemia Drugss
June 24
TMC649128 enters Phase Ib Trial in Patients Chronically Infected with Genotype-1 Hepatitis C Virus
June 22
Achillion Initiates 12-Week Dosing in Phase 2 Trial of ACH-1625 for the Treatment of Chronic Hepatitis C
June 22
Angioplasty May Be Feasible for Liver Transplantation Candidates with Heart Disease
June 22
NAT Screening May Lower Undetected Hep C in Donors
June 21
Hep A Immune Response Mystery Has Implications for Hep C Research
June 21
Activists Call for Earlier Access to Hep C Treatments
June 16
A Better Way to Detect Infections in Donated Organs
June 16
Noninvasive Liver Tests May Predict Hepatitis C Patient Survival
June 14
Analysis Finds Mortality from All Causes Higher Among Hepatitis C-Infected
June 11
Noninvasive Tests Reduce Need for Liver Biopsies in Hep C
June 11
Scientists Create Humanized Mouse Model for Hepatitis C
June 8
Pharmasset Announces the Expansion of the ELECTRON Trial in Chronic Hepatitis C
June 8
Patient Acceptance of Universal Screening for Hepatitis C Virus Infection
June 7
Shorter Treatment for Acute Hep C Works in HIV-Coinfected MSM
June 2
Videoconferencing Enables PCPs to Deliver Specialist-Quality Hep C Treatment
June 2
Noninvasive Diagnostics May Offer Alternative to Liver Biopsy for Assessing Liver Fibrosis
June 2
Heavy Coffee Consumption Linked to Better Hep C Treatment Response
June 1
Clincial Trial Evaluating 16 and 24 Weeks of a Four-Drug Regimen and 24 Weeks of a Three-Drug Regimen of GS-9451, Peginterferon Alfa 2a (PEG, Pegasys®) and Ribavirin (RBV, Copegus®) With and Without Tegobuvir (GS-9190)
May 28
All-Oral Combination Study with PSI-7977 for HCV Genotypes 1, 2 and 3 Initiated + BMS NS5A BMS-790052
May 26
New Drugs Encouraging for African Americans with Hepatitis C
May 26
The Fair Pricing Coalition Expresses Disappointment at the Price of Vertex’s Newly Approved Hepatitis C Drug
May 25
Arrival of Direct Antiviral Agent Therapy for Hepatitis C Sparks Debate of Who to Treat First
May 25
Gene Associated with Increased Risk of Cirrhosis for HIV/HCV-Co-Infected Patients
May 24
European Approval Recommended for Hepatitis C Drug Boceprevir
May 23
FDA Approves Incivek (Telaprevir) for Hepatitis C
May 23
Merck's Hepatitis C Drug Victrelis Gets Positive Opinion from European Regulator
May 20
Medivir Announces Positive 48-week Interim Data from TMC435 Hepatitis C Phase 2b ASPIRE Study in Treatment-Experienced Genotype-1 Patients
May 20
MK-5172 New Merck Protease Phase 2 Study Starts
May 18
Merck and Roche Establish Strategic Agreements in Fight Against Chronic Hepatitis C
May 17
FDA approves Victrelis for Hepatitis C
May 13
Action Plan to Address the Silent Epidemic of Viral Hepatitis Released by the Department of Health and Human Services
May 13
Diagnosis of Hepatitis C is More Urgent Than Prevention
May 12
UPMC Confirms Patient Got Kidney from Donor with Hepatitis C
May 11
Age-Based Hep C Screening May Work Better Than Risk-Based Screening
May 9
Hepatitis C Cases on Rise among Massachusetts Youth
May 5
Merck & Co’s Victrelis and Vertex’ Telaprevir Get Unanimous Backing from FDA Advisory Panel for Chronic Hep C
Apr 29
FDA Says Vertex Hepatitis Drug is Highly Effective
Apr 27
Merck Pitches Hepatitis C Drug to U.S. FDA Panel
Apr 27
Severity of Hepatitis C and HIV Co-Infection in Mothers Contribute to HCV Transmission to Child
Apr 27
FDA Backs Vertex Hepatitis Drug Efficacy, Shares Jump
Apr 26
FDA Sees Safety Issue with Merck Hepatitis Drug
Apr 25
On the Long, Hard Road to a Breakthrough
Apr 24
Idera Pharmaceuticals Delays Initiation of Phase 2 Clinical Trial of IMO-2125 in Treatment-Naïve HCV Patients
Apr 22
Genetics of Hepatitis C Linked Hepatocellular Carcinoma
Apr 21
Merck, Vertex Prep
for Hep C Drug Panels
Apr 21
Transgene, ChronTech Pharma and Inovio Pharmaceuticals to Collaborate on Heterologous Prime-Boost Therapeutic Vaccination Against Hepatitis C
Apr 18
Quest Diagnostics Launches Hepatitis C Virus Therapy Test Based on IL28B Gene Variants
Apr 18
New Compounds Show Promise against Hepatitis C Infection
Apr 12
New Analysis Finds Antidepressants Boost Patient Adherence to Hepatitis C Treatment
Apr 11
Big picture of how interferon-induced genes launch antiviral defenses revealed
Apr 11
FDA Approves Special Protocol Assessment for Phase 3 Trial of Polaris Group's Cancer Therapeutic, ADI-PEG 20, in the Treatment of Hepatocellular Carcinoma
Mar 31
Inhibitex Reports Positive Safety and Antiviral Data from Its Phase 1b Study of HCV Nucleotide Inhibitor INX-189
Mar 31
Drug Cocktail Offers New Hope for Hepatitis C Patients
Mar 31
Presidio Pharmaceuticals, Inc. Announces Positive Results in a Phase 1b Clinical Trial of PPI-461, a Novel, Potent Broadly-Active Hepatitis C Virus (HCV) Inhibitor
Mar 30
Pharmasset Initiates Phase 2b ATOMIC Trial of PSI-7977 for Multiple HCV Genotypes
Mar 30
Achillion Announces Positive RVR Results With ACH-1625 to Treat Chronic Hepatitis C
Mar 30
Santaris Pharma A/S advances miravirsen, the first microRNA-targeted drug to enter clinical trials, into Phase 2 to treat patients infected with Hepatitis C virus
Mar 21
The Relationship between Body Mass Index and Age at Hepatocellular Carcinoma Onset in HCV-Infected Patients
Mar 17
Outcomes Differ Among Hepatitis C-Related Vasculitides
Mar 16
Achillion Granted U.S. Patent for ACH-1625 and Related Protease Inhibitors
Mar 16
HCSP Launches New Hepatitis and Tattoos Site
Mar 15
FDA Panel To Review Merck, Vertex Hepatitis Drugs In Late April
Mar 15
iTherX Initiates Phase 1b Study of First-in-Class Hepatitis C Virus Entry Inhibitor ITX-5061
Mar 15
Inovio Pharmaceuticals' Partner ChronTech Initiates Phase II Clinical Trial of Hepatitis C Virus DNA Vaccine Using Inovio's Electroporation Delivery Technology
Mar 14
An Unusually High Cure Rate Recorded after ChronVac-C® Vaccination Followed by Standard Treatment in Patients with Genotype 1 Chronic Hepatitis C
March 8
Pharmasset Hep C Data Wows Investors
March 8
New Treatments For Liver Cancer
March 4
IL28B Gene Predicts Treatment Outcome for Liver Transplantation Patients
March 3
9 Dayton VA Dental Patients Test Positive for Hepatitis
March 2
Scripps Pioneers Individualized Medicine by Offering Genetic Testing to Hepatitis C Patients
Feb 25
SVR Signals Good Prognosis in Decompensated Cirrhosis Due to HCV
Feb 24
Lack of Health Insurance Limits Hepatitis C Patients' Access to Latest Antiviral Therapy
Feb 24
New Vaccine Technology Protects Mice from Hepatitis C Virus
Feb 23
OraSure Technologies Receives FDA Approval for Its OraQuick(R) HCV Rapid Test Using Fingerstick Whole Blood
Feb 22
Medivir Announces Positive Phase 2b 48-week (SVR24) Interim Results of TMC435 in Treatment-Naive Patients Chronically Infected With Genotype-1 Hepatitis C Virus
Feb 22
Tibotec Starts Global Phase 3 Clinical Trials Studying TMC435 in Adults With Chronic Genotype 1 HCV
Feb 18
Conatus Pharmaceuticals Initiates Confirmatory Phase 2 Clinical Trial of CTS-1027 for the Treatment of Hepatitis C Virus (HCV)
Feb 17
U.S. Hepatitis C Cases Down Sharply Since 1980s
Feb 15
San Francisco Needs a Supervised Injection Clinic
Feb 15
NVHR: Administration's 2012 Budget Proposal Represents 'Sea Change' in National Response to Viral Hepatitis Epidemic
Feb 14
Inhibitex Receives Fast Track Designation for INX-189 for the Treatment of Chronic Hepatitis C Infections
Feb 11
Idenix Pharmaceuticals Provides Updates on Three Clinical Development Programs
Feb 10
Medivir Announces Start of Phase 1a Trial of the Hepatitis C Polymerase Inhibitor TMC649128
Feb 10
Study Finds Little Decline in Hepatitis C Infections Among Injection Drug Users
Feb 3
Study Examines Incident Hepatitis C Infection in HIV-Infected Men
Feb 3
Illinois Must Pay Damages for Prison Hepatitis Policy
Jan 31
Researchers Identify Gene Variants Linked to Hepatitis C Treatment-Related Anemia
Jan 25
Patients Infected with HIV have Higher Drop-Out Rate for Liver Transplantation
Jan 25
San Francisco Hepatitis C Task Force Releases Recommendations for Fighting Epidemic
Jan 24
Local Group Helping Find Cure for Hepatitis C
Jan 19
First Liver Transplant Patients Receive Experimental Drug to Prevent Hepatitis C Infection
Jan 18
New Hope for Hepatitis C, an Often Hidden Disease
Jan 17
Complete Response for Advanced Liver Cancer During Sorafenib Therapy: Case Report
Jan 17
Peregrine Initiates Randomized Phase II Trial of Bavituximab in Chronic Hepatitis C Open-Label Trial Evaluating 12 Weeks of Therapy with Novel Targeted Antibody Bavituximab in Combination With Ribavirin Versus Standard of Care
Jan 10
Vertex Announces Key Business Objectives To Support Planned Launch of Telaprevir in Hepatitis C and Continued Progress in Other Serious Diseases
Jan 10
Inhibitex Reports Positive Interim Safety and Antiviral Data from Ongoing Phase 1b Study of HCV Nucleotide Inhibitor INX-189
Jan 10
Bristol-Myers Squibb and Pharmasset Enter into a Clinical Collaboration Agreement for Proof of Concept Combination Study in Patients Chronically Infected with Hepatitis C
Jan 10
Hepatitis C: In 2011, a Predictive Marker for Response to Therapy
Jan 7
Metabolic Syndrome Found in 52 Percent of Patients after Liver Transplantation
Jan 6
Pharmasset Reports Positive Results from its HCV Clinical Programs
Jan 6
Boceprevir, Merck's Investigational Oral Hepatitis C Protease Inhibitor, Receives FDA Priority Review and EMA Accelerated Assessment
Jan 6
Top News 2010
INFECTION FILES: Seafood Safety Concerns for Those with Liver Disease
Dec 30
Scripps Research Scientists Identify Key Interaction In Hepatitis C Virus
Dec 30
Harm Reduction Moving Mainstream
Dec 27
Fish Pedicures Could Spread HIV and Hepatitis, Says UAE Ministry of Health
Dec 22
Vietnamese Pharmaceutical Firm Faces Patent Lawsuit
Dec 22
Janssen-Cilag Applies for EU Approval of Hepatitis C Drug
Dec 22
Vertex Provides Update to Ongoing Phase 2 Study Evaluating Combinations of Telaprevir and VX-222 for the Treatment of Hepatitis C
Dec 21
Infectious Diseases Kill Thousands: Ontario Atudy
Dec 15
The Voices of Hepatitis
Dec 15
Hepatitis Experts Create Roadmap for Accelerating the Development of Targeted Therapies for Hepatitis C Virus Dec 14
National Transplant Medical Experts Insist Arizona Transplant Cuts are Based on Flawed Data Dec 9
Anemia in Treated-HCV Patients Bodes Well for Sustained Virologic Response Dec 6
Safe Injection Sites Will Open with or without Permission Dec 1
On Eve of World Aids Day, Yee Recommits to Sterile Syringe Bill Dec 1
First-Ever Covalent Irreversible Inhibition of a Protease Central to Hepatitis C Infection Nov 28
Vertex Completes New Drug Application for Telaprevir for Hepatitis C Nov 23
Antiviral “Cocktail” Better than Single Drug for Children with Hepatitis C Nov 10
Polymorphism Associated with Good Antiviral Response but Also Depression in HCV Nov 4
Growth Factor Drugs Bolster Compliance in Hepatitis C Therapy Nov 3
Abbott Hep C Drug ABT-450/r Impresses in Mid-Stage Trial Nov 2
Avila Presents New Data on its Novel, Orally-Available Targeted Covalent Drug, AVL-192 Nov 2
AASLD: HCV 'Cure' Now on Agenda Nov 2
Final Results of Clinical Trial on Boceprevir Nov 1
NVHR Welcomes Dr. Koh's Remarks at AASLD, but Warns that Viral Hepatitis Battle Demands Decisive National Leadership Nov 1
Mortality Rates from Liver Diseases Underestimated Nov 1
Hep C Update: Vertex, Merck and Gilead Oct 31
AASLD: Successful HCV Tx Cuts Deaths Post-Transplant Oct 31
First Human Liver Grown in Lab Oct 29
Hepatitis C Iincreased Risks for Cerebrovascular-Related Death Oct 28
Journal Review
 June 25, 2010
May 24, 2010
April 28, 2010
March 29, 2010
February 24, 2010
January 24, 2010
Journal Review
December 22, 2009
November 30, 2009
October 28, 2009
September 28, 2009
August 26, 2009
July 27, 2009
June 29, 2009
May 25, 2009
April 29, 2009
March 25, 2009
February 28, 2009
January 15, 2009
Journal Review
December 15 , 2008
November 15 , 2008
October 15 , 2008
September 15 , 2008
August 15 , 2008
July 15 , 2008
June 15 , 2008
May 15 , 2008
April 15 , 2008
February 10 , 2008
January 25 , 2008
January 15 , 2008
|
